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dialogue

Using technology to
drive scientific advances
      have a long tradition of innovation in the
technology sphere. Robert J. Alpern, MD, dean and Ensign Professor of Medicine, discusses the school’s current technological strengths and initiatives he believes will help
continue carrying the school forward into the 21st century.
How is Yale School of Medicine taking advantage of advances in technology? Increasingly, advances in
science are limited by advances in technology. In some fields, without certain devices, it’s impossible to conduct clinical research. Top schools, including Yale, have to identify which cutting-edge
technologies will give science and researchers the best opportunities, and invest in them. Advanced
technologies are often very expensive in terms of money and expertise, so we’ve stepped forward to
fund facilities that have the potential to be widely used by researchers. Cryo-electron microscopy
is one recent example of this; no individual investigator could afford it, so the medical school and
the provost’s office made a major investment in cryo-electron microscopy. Not just purchasing the
equipment and finding a space for it, but also creating a core with technical expertise so that investigators who need it for research but lack the mechanical know-how are able to use it.
How has that changed over your tenure? We’re able to do extraordinary things that just weren’t possible 20 years ago. A great example of this is DNA sequencing. When the instrumentation became
available so that any university could perform state-of-the-art DNA or RNA sequencing, Yale made
major investments so investigators could have access to this technology. Those who have made use of
this resource say it’s been a game-changer.
What has spurred those changes here at Yale? From the moment I stepped on campus, it became clear

to me that one of the people really driving investment in technology to support research was Carolyn
Slayman. Carolyn always believed in supporting this cause, and as the medical school’s finances have
improved, it’s been easier to support more and different technological investments for faculty and
students. This type of thinking is now common in the top schools, but Carolyn was ahead of her time.
What does the school do if a device is difficult to use or to maintain? It depends. In some cases, it’s just

a question of giving researchers access and training and they’ll be able to use the device themselves.
In the case of the cryo-electron microscope, the machine is so complex that many investigators just
don’t know how to operate it correctly, and if they make an error, they’ll break it. Some investigators
can use it properly and do, in their research. For those who need it, we make certain technical assistance is available. The point is to facilitate research, not bog scientists down with tasks outside their
realm of expertise.
How does YSM differ from competitor institutions? I tend to think about how we’re similar to other top
institutions—which strengths are common to leading innovators. First of all, we want to develop technology that’s useful to science and medicine. Second, if we can’t develop it ourselves, we want to be early
adopters when others develop an exciting new device. DNA sequencing, again, was a place where we
couldn’t develop or adopt at first—if you weren’t part of the Human Genome Project you couldn’t build
the DNA sequencers they were using. As soon as the DNA sequencers were developed commercially, we
invested in resourcing our faculty with that capability. And it’s really offered our scientists an advantage.
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Prolific publication:
One lab’s secret
to success
   meets every Friday in an office suite of
the orthopaedics department. Medical students, several
residents, and a few attending physicians sit around the
table, eyes fixed on a monitor at the front of the small
conference room. They’re examining graphs and tables
designed to explain the significance of medical data from
thousands of patients across the country.
Lab members comb through
national (sometimes Yalespecific) medical databases
looking at outcomes of interest
in the field of orthopaedics. By
analyzing data from thousands
of patients, they can gauge how
well a treatment works; determine which conditions lead to
surgical complications; and propose ways to optimize outcomes.
To come up with research
ideas, the group reads through
published studies and asks how
the so-called big data approach
might find better answers to
existing questions. “We define
questions raised from the literature or from local discussions and see what we have the
tools to answer well. Often, we
can resolve questions that have
not been answered in the past,
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or use larger or more defined
patient populations to address
questions in novel ways,” said
Jonathan N. Grauer, MD, interim
chair and professor of orthopaedics and rehabilitation, and codirector of the Spine Center at
Yale New Haven Hospital.
When Grauer joined the Yale
faculty in 2003, he worked in
a lab conducting preclinical animal studies focused on bone formation and spinal fusion. Over
time his work evolved, and his
research now relies on software
and big data.
Grauer’s conversion to this
type of research came in 2012

when a student approached him
with an idea for a study. Rafael
Buerba-Siller, MD ’14, MHS ’14,
then a Yale medical student,
asked Grauer whether he would
be willing to help him apply
big data research techniques
to orthopaedics. Previously,
Buerba-Siller had used such tools
for studies in endocrine surgery.
Grauer agreed to help: “And sure
enough the study went great,”
he said, opening “doors to novel
approaches in orthopaedics and
spine research.”
The focus of Grauer’s research
shifted from gathering data to
posing questions, assessing data,
and deriving clinically useful
conclusions. By applying contemporary clinical questions to
big data sets, Grauer’s Lab performed more and more studies
on varying topics in spine surgery and orthopaedics.
“I think [the lab] ranks pretty
high in terms of productivity,”
said Lee E. Rubin, MD, HS ’09,
associate professor of orthopaedics and rehabilitation, who
works with Grauer and helps
guide the student members of the
lab. He estimates that among the
medical students who spend a full
year of research in the Grauer Lab,
“each will typically achieve 10 to
15 completed projects that are
presented or published.”
Pat Bovonratwet, MD ’19,
joined the Grauer lab in 2016
after his first year at Yale. “The
upperclassmen had always
told me, ‘Dr. Grauer’s the man
to go to if you’re interested in
orthopaedic research,’ ” he

R O B E R T L I S A K P H OTO

said. At the end of that summer, Bovonratwet published his
first first-author paper. Since
then, he has published a total of
33 peer-reviewed papers from
the Grauer Lab. Bovonratwet
is listed as first author on 14 of
those papers.
This level of achievement is
not unusual among the students
in the Grauer Lab. “He’s very
inclusive of medical students,”
said Bovonratwet. “When I
first joined, he told me, ‘I will
always support you and your costudents in leading the studies.’ ”
Grauer gives the medical students autonomy when it comes
to research, guiding them at each
step of the research process, and
“helping them to develop their
researcher skills,” Grauer said.
The lab is focused on making a clinical difference. “We
review these projects at every
stage,” said Rubin. “Almost all
of these publications find a way
in [to journals] because it’s highquality research.”
Part of the reason the lab can
boast this high quality is that its
members scrutinize the limitations of their methods. “We’ve
written many papers that call
out the limitations of the type
of research we do,” said Grauer.
“In doing so, we become credible
in the conclusions that we draw.”
According to Bovonratwet,
aside from the research experience, lab members also benefit from a dedicated mentor
and a network of lab alumni.
Bovonratwet noted that many of
Grauer’s previous lab members

still remain involved, giving
current members guidance,
resources, or project ideas.
This network is derived from
Grauer’s dedication to research
and his group. “He is a great
mentor and supports his students through medical school
and beyond,” said Bovonratwet.
—Jackie Rocheleau

»

MakeHaven includes
those interested in or
connected to medicine

Gina Siddiqui, MD, had scarcely
handled a screwdriver when she
set foot last August in MakeHaven,
the makerspace in downtown
New Haven. “I didn’t know the
difference between a screw and
a bolt,” said Siddiqui, who’s in
her third year of an emergency
medicine residency at Yale New
Haven Hospital. Over the course
of the next 30 days, with training
from MakeHaven staff, she mastered everything from a hammer
and chisel to a laser cutter as she
built her husband a present for his
birthday in early September—a
large format view camera.
Working with maple and
balsa wood, she crafted a camera
with a holder for 5x7-inch film
negatives, a tripod mount, and
railings to support the bellows
and lens she bought from a photo
supply house. “I found it incredibly invigorating,” Siddiqui said.
MakeHaven is one of about
100 community-based makerspaces around the country—part
of a growing movement that

emerged in the early 2000s as
inventors, tinkerers, hobbyists,
and artisans banded together to
ply their crafts and indulge their
passion for creativity. The fruits
of those labors ranged from
inventions that would obtain
patents and spawn companies to
toys that glow in the dark.
“There is some fundamental
need and satisfaction in making
something,” said MakeHaven
board member Joel Greenwood,
PhD, director of neurotechnology in the Department of
Neuroscience at the School
of Medicine. “We are getting
further and further away from
making things,” he lamented.
His passion for building
comes from his childhood on a
farm an hour south of Seattle,
where his parents lived off
the land, growing vegetables,

Jonathan Grauer’s lab has
an impressive record of
publications. The secret is
using big data to identify
likely problem areas with
orthopaedic surgery, as
well as potential solutions.
After his patients, Grauer’s
students have been
among the greatest beneficiaries of this efficient
and effective process.
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In 1965, a land mine
landed Yale graduate
George Cadwalader
in a steamy tent of the
3rd Surgical Mobile
Hospital (MASH) in
Vietnam. Little did he
suspect that his surgeon, Captain Kristaps
Keggi of the 173rd
Airborne, was another
son of Eli. Keggi, a YSM
graduate, would save
Cadwalder’s legs, and
the two formed an
unlikely friendship.
For more on their experience in Vietnam and
after, visit ymm.yale.edu/
battlebuddies
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and raising sheep and chickens. Greenwood’s father was a
home builder who had a twostory woodshop on the property. “I grew up building stuff,”
Greenwood said. At Yale, he
helps neuroscientists solve problems by teaching them to build
the tools they’ll need, or directing them to people who can
make equipment for them.
Like its peer spaces around
the country, MakeHaven offers
its 300 members a place to
work, access to tools, and a
like-minded community that
provides feedback and shares
ideas and techniques. While
New Haven has other makerspaces, like Yale’s Center for
Engineering Innovation and
Design, MakeHaven is the only
one that’s open to the community at large.
The seeds for MakeHaven
sprouted at a meetup in 2012.
When critical mass grew to
about 50 people, the participants chipped in to rent space
on State Street and rummaged
through their homes for tools.
“Not all the tools were of the best
quality,” said J.R. Logan, one of
the founders and now executive director. “They were handme-downs.” In March 2018,
MakeHaven moved to a larger
space—5,000 square feet in the
basement of 770 Chapel Street,
a building that also houses
SeeClickFix. Tools are no longer
basement relics: they include
woodworking and metalworking equipment, an electronics
workbench, 3D printers, sewing

machines, printing presses, and
a home brewing machine. In
addition to space, tools, and
training, MakeHaven offers
talks, classes, and workshops.
As MakeHaven grew, members
realized they could no longer rely
on volunteers to run the place day
to day. Logan, whose father was
an inventor, was the first fulltime employee. Kate Cebik works
full time as operations manager.
Lior Treshman is MakeHaven’s
part-time “maker guru.”
The space sustains itself with
dues ($50 per month, $35 for
students) and grants, including one from CTNext, which
supports companies and entrepreneurs with funding and
mentorship programs. Members
come with a variety of ambitions. Some have patented their
inventions, and some have given
up their day jobs to pursue their
projects. Others are hobbyists and tinkerers. “They fi nd
joy in whatever is their area of
technology,” said Logan. “They
wanted a platform and to be able

to share it. It has broadened and
gotten bigger.”
On a recent weekday, Nick
McGhee was editing a presentation he and colleagues
are making for a NASA design
competition—a prototype of a
human habitat for Mars. Upon
their arrival on Mars, pioneers
will need tools to turn Martian
raw materials into a permanent
home. “The project we worked
on is to develop the necessary
technology,” said McGhee, who
recently left his job as an aerospace engineer to devote himself
to the project. His project took
third place and won $32,000.
Another member has used
MakeHaven’s 3D printer to make
prosthetic hands for children
in the developing world. One
member is working on a quadcopter, which is a helicopter
lifted and propelled by four
rotors. Still another is using DIY
instructions available online to
make a book scanner.
Like others involved in
MakeHaven, founding member Ben Berkowitz, the CEO
of SeeClickFix, grew up making things—his father was a
carpenter. The past chair of
MakeHaven’s board, he still

R O B E R T L I S A K P H OTO
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makes toys for his children
and decorations for his office.
“MakeHaven,” he said, “is a
place to learn new skills and
share ideas, to build businesses,
and for anyone to achieve their
dreams of making something
with their hands.”
—John Curtis

»

Treating childhood
autism one robot
at a time

M AT T H E W DA L E Y I L LU S T R ATO N

Parents can be resistant to hearing that their child faces a challenging health diagnosis. But
when Thomas Leaf and Emanuela
Palmares learned that their
son Caio has autism spectrum
disorder (ASD), the diagnosis
answered many questions with
which they’d been grappling as
parents and as individuals.
It wasn’t clear to them that
Caio might be on the autism
spectrum. Only after their
insurance stopped covering
hearing tests nearing Caio’s
third birthday, did the two
bring him into Yale’s Child
Study Center to undergo evaluation for a study. It turned out to
be a wise decision.
“When they described Caio’s
behavior in terms of autism, a lot
of things clicked into place,” said
Leaf. “His focus on a tree on the
horizon and tuning the rest of the
world out. His fixating on a soccer line during a soccer game and
ignoring the game around him.
His difficulty discriminating foreground from background noise.”

“I had some trouble as a kid—
acting out, throwing tantrums—
feeling misunderstood and
apart. That’s an awful thing to
go through when you’re young,
and autism is the kind of disorder that, without therapy, can
make alienation worse,” said
Leaf. “Hearing Caio’s diagnosis,
we wanted to give him the best
treatment as soon as possible.”
“For the first 18 months,
we’d been raising an infant,
basically,” said Palmares.
“Once we embraced what was
happening, though, we started
seeing improvements in Caio
almost immediately.”
ASD affects approximately 1 in
59 children, and is nearly four
times more likely to be diagnosed
in boys than girls, according to
the Centers for Disease Control
and Prevention. While many
children are diagnosed after age 4,
there are reliable mechanisms for
diagnosing children earlier. The
earlier children are diagnosed, of
course, the more effective treatment can be. Caio’s diagnosis
at the age of 3 put him in a good
position to lead the kind of life
available to most children, fully
integrated into society.
Fred Volkmar, MD, the Irving
B. Harris Professor in the Child
Study Center and professor of
psychology, is one of the people
driving efforts to expand early
diagnosis and treatment of
children with ASD. He said that
just in his lifetime he’s watched
autism go from a once littleunderstood diagnosis considered by many a kind of lifetime

prison sentence (think Dustin
Hoffman’s character in Rain
Man) to a fully treatable condition, driven by a wealth
of research.
“I’ve served as an editor for the
Journal of ASD, and the number
of submissions we get to publish
papers has really taken off over the
last 10 years,” said Volkmar.
Even so, Volkmar said that
there were gaps in research
and treatment—specifically,
studying two very promising
fields, robotics and smartphone
applications. Children on the
autism spectrum have trouble
with what psychologists call
executive functions: monitoring multiple stimuli and completing complex tasks. Social
interactions are among the most
complicated tasks humans perform many times over on a daily
basis. Navigating those interactions can quickly overwhelm
children with ASD, which
explains why they have difficulties interacting with others as well as with the specific

OPPOSITE New Haven’s

MakeHaven is one of
a network of makers
communities across the
country where innovationminded citizens pool
resources to buy and
use machines few could
afford on their own.
Yale School of Medicine
faculty and students
have been known to use
the facilities.
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YSM’s clinical research
arm has benefited
from two substantial
behind-the-scenes
technological advances. Sometimes
software and integration of systems can
produce outsize
operational results.
For more on YSM’s
clinical research arm,
visit ymm.yale.edu/
electronicrecords
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with the robot, is helping it to
perform tasks to get its spaceship
working again. At the end of the
study, the robot has fixed its ship
and can return to space, leaving
the child’s home,” said Scassellati.
challenges they face in profes“This story helps the children
sional environments.
build empathy at the same time
“Children on the autism specthat they’re building social skills,
trum get only about 10% of the
and makes the departure of the
social affective information in
robot less disruptive.”
a scene, in large part because
Thus far, feedback has been
they’re looking at mouths, not
eyes,” said Volkmar. “The top half extraordinarily and overwhelmingly positive, accordof the face is where the action
ing to Scassellati. “All of the
is, socially speaking, in terms of
children in the study made
nonverbal communication.”
significant gains in their social
Robots are interactive partskills, and the robots were
ners with which children on the
very well received. The parents
autism spectrum can feel comdon’t want the robots to leave;
fortable because there is little or
even more so than the children,
no nonverbal communication.
even.” He said that after the
This simplicity can help children
robots left, some of the children
learn to express themselves
lost the gains they had made,
without anxiety, which in turn
but that in and of itself isn’t
can lead to better interactions
exceptional. “We didn’t expect
with humans in the child’s life
the robots to create permanent
(adults, siblings, and friends).
changes after just a month. Our
Brian Scassellati, PhD, the
best therapies don’t work that
A. Bartlett Giamatti Professor
quickly,” he said.
of Computer Science and
Apps are another way to
Mechanical Engineering and
help children with ASD. David
Materials Science, is developGrodberg, MD, FW ’99, assising robots designed specifically
tant professor of psychiatry and
to help children on the autism
medical director of the Child
spectrum improve social skills.
Study Center’s Outpatient Clinic,
He has worked with the Child
has been developing an applicaStudy Center and Volkmar to
tion to help parents learn to use
ensure that the robots are idethe same behavioral intervenally designed for children with
ASD, down to a narrative for their tions with their children that
are used by experts. “Much of
arrival in the house and their
the important work that’s done
imminent departure. This narby professionals in a clinical setrative has been tested in a recent
ting can—must, really—be augstudy that was published in
mented by engaging the parents
Science Robotics in August 2018.
“From the first moment in
the house, the robot tells a story
about how it is a space explorer
whose spaceship has broken
down. The child, in interacting

and other caregivers,” he said.
Giving them tools to guide their
treatment plans along carefully
prescribed lines and with feedback from clinicians is key, he
said, to maximizing the benefit
to affected children.
Palmares, who has since
remarried, noted that having a
child with ASD requires great
efforts as a parent, but also that
the process has been personally
rewarding. “Caio has made me a
better mother and a better wife,”
she said. She and Leaf divorced
not long after Caio’s diagnosis,
for reasons unrelated to his condition, and “co-parenting him
has allowed both of us to forgive
each other and have a healthy,
respectful relationship. We have
to, for Caio’s sake.”
Leaf agreed. “I think
Emanuela and I both see raising
Caio as a call to make ourselves
better people. I remember my
childhood, growing up as an
outsider, not really feeling at
home until I went to Hopkins
[a private school in New Haven].
Caio’s never going to feel like
he’s a bad kid, like he’s weird or
unaccepted. He is who he is.”
Caio has become adept at using
educational apps, and has his own
programmable robot that he loves
playing with. He’s even mastered
a form of programming to get
the robot to perform different
tasks. Increasingly, what could
have been a debilitating condition
is for Caio and children like
him, just another one of life’s
manageable challenges.
—Adrian Bonenberger

a collection of recent
scientific findings

COUNSELING PARENTS TO
HELP TREAT KIDS’ ANXIETY
One in three American children will experience a clinically significant anxiety disorder before adulthood. Eli Lebowitz, PhD,
associate professor in the Child Study
Center, recently conducted a study that
concluded that counseling the parents
of anxious children can be as effective
in treating common anxiety disorders
as cognitive behavioral therapy for the
children. Lebowitz’s program is called
SPACE (Supportive Parenting for Anxious
Childhood Emotions). Parents in the
SPACE program are counseled to be less
accommodating; that is, to reduce the
number of changes they make in their own
behavior to lower the child’s distress.

MEMORY LOSS
IN OPIOID USE

G E T T Y I M AG E S

Clusters of people with a history of opioid use who present
without the ability to form
new memories—a kind of brain
damage—may offer a clue to
amnesia, inflammation, and the
process of memory loss. Adam
Jasne, MD, assistant professor
of neurology, observed swelling
in the cerebellum and hippocampus (a part of the brain
involved in memory formation)
in six drug-overdose patients
suffering from amnesia.
Sometimes the brain swelling
is fatal, and even when it isn’t,
the patient can have permanent memory impairment
along with such physical problems as movement abnormalities and seizures.

TEXTING FOR A
HEALTHY HEART
A project involving researchers at Yale and in China
gauges the potential for
smartphones to improve
heart health in a country with
high rates of heart disease.
Patients in different regions
across China diagnosed with
chronic heart conditions
received supportive text messages as well as texts offering
guidance on daily activities to
support specific health goals.
While the messages did not
result in significant changes
to the participants’ blood
pressure, most of the subjects
liked them and wanted to continue to receive informational
and motivational support
after the study ended.

UNDERSTANDING
WOUND CLOSURE

Together with researchers at
University College London, scientists at Yale looked closely
at how cells behave when
repairing skin tissue. By using
traction force microscopy, the
researchers identified two
mechanisms by which muscle
proteins are brought to the
edge of a wound to close it:
using protein actin projections called lamellipodia at the
leading edge of a cell to move
the entire cell, or by forming
a “purse string” bundle of cells
across the leading edge of the
wound. Understanding these
coordinated cellular behaviors
will help researchers develop
new methods of healing physical trauma.

RACIAL DISPARITIES IN
KIDNEY TRANSPLANT
The kidney, according to the
Centers for Disease Control
and Prevention, is among the six
most commonly transplanted
organs in the United States.
Recent research indicates,
however, that Black patients
encounter significantly more
difficulty in receiving a kidney
for transplantation. The reasons
for the disparity are not completely clear, but one major factor is that Black patients are less
likely to be moved from inactive
to active status on the transplant waiting list after initial listing. Researchers suggest that
better coordination between
kidney dialysis units and transplant centers would help solve
the problem.
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Technology: A tool for treatment
A S D O C TO R S AN D R E S E ARC H ER S become increasingly specialized in
their fields, so too do the tools and technology they use to diagnose and treat patients as well as conduct research. These tools are themselves the product of expertise, and one of the strengths of Yale School of Medicine (YSM) is the wealth
of informal and formal collaborations between clinicians and inventors.
This issue looks at some of those technological collaborations among doctors, scientists, and engineers that have led to breakthroughs, as well as innovations that are ongoing or imminent. Abby Roth’s “Honing clinical skills with ultrasound” considers how advances in machines, as well as such pedagogical tools
as smart tablets, can help students hone their skills before setting foot in the
clinic. Ken Byron writes about an undergraduate class in biomedical engineering
co-taught by assistant professor of surgery Daniel Wiznia, MD, and Steven Tommasini, PhD, which focuses on engineering solutions to real-world orthopaedics
problems. And former Yale Medicine Magazine editor John Curtis has compiled
a timeline of medical innovation that sets some of Yale’s and YSM’s more notable
achievements in historical context.
There’s a lot more—the synthesis between imaging and 3D printing could
take up a whole issue by itself, and there are several stories in these pages that
dive into advances in that field.
It’s an exciting time to be working on technological solutions to medical
problems, and YSM is proud to offer workshops, laboratories, and funding to
people who contribute to that work.
The new machinery of medicine
Building lung capacity, lung-first
A perfect day for a zebrafish
Where scientists and entrepreneurs mingle
Honing clinical skills with ultrasound
Engineering innovation
When skin-deep is all you need
Scratching the surface: Metallic glass implants
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the new machinery
of medicine
by steve hamm | robert lisak photo

For patients suffering from genetic disorders or diseases that
may be cured by a combination of three new technologies,
the clinical applications can’t come quickly enough.
Just four months after Elsa Violante was born, she
began to have seizures. The spasms lasted from 30 seconds to four minutes, and they came every 15 minutes
to half an hour. Her parents, Alexis and Christiane
Violante, rushed her to her pediatrician near their
home in suburban Toronto. He sent them to the emergency department of a downtown hospital.
The diagnosis was early infantile epileptic encephalopathy, a rare and serious condition that can have
debilitating lifelong effects. “After they told us what it
really was, it became terrifying,” says Alexis.
Physicians at the Hospital for Sick Children
(SickKids) in Toronto tried one treatment after another
to address Elsa’s seizures, but they couldn’t identify
the underlying cause. So they sent the
family’s blood tests to Yale Medicine’s Pediatric
Genomics Discovery Program (PGDP). Using gene
sequencing machines, high-performance computers,
and CRISPR-Cas9 genome editing technologies,
the PGDP team discovered that a rare variant of the
gene NEUROD2 on chromosome 17 is responsible
for Elsa’s condition.
Ultimately, a high-fat low-carbohydrate diet
addressed Elsa’s seizures, but physicians can’t repair
her damaged nervous system. At age 5, she is unable
to walk or even sit up, and she has limited control of
her arms and hands. Yet her parents hope that medical
science will produce advances that will make Elsa’s life
better—and that the discovery of the NEUROD2 variant
will help other kids and families.
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Elsa’s story illustrates a powerful melding of technologies that’s helping to solve the mysteries of life
and to usher in the era of precision medicine. Gene
sequencing, computer data analysis, and the simulation of scenarios using experimental genome editing
techniques enable researchers to identify and understand the differences among people on the genetic
level. As a result, we can better diagnose diseases and
choose—or design—treatments tailored to help individual patients. “From the standpoint of medicine and
health, this can be transformative—and in ways that
we can’t even appreciate now,” says Saquib Lakhani,
MD, assistant professor of pediatrics and clinical director of the PGDP program.
Yet this combination of tools is just one of many
applications of technology to medicine that are changing the ways medical researchers do their work and
physicians treat patients. For decades, technology has
played a critical role in medicine. From the iron lung
in 1929 through the cardiac pacemaker, the artificial
heart, and robotic surgery in more recent times, engineers and medical scientists have long collaborated to
produce innovations at the intersections of their fields.
Yale faculty members have been in the vanguard.
Scientists and clinicians here were pioneers in the
use of magnetic resonance imaging (MRI) machines.
William V. Tamborlane, MD, FW ’77, professor of
pediatrics, and Robert S. Sherwin, MD, FW ’74, the
C.N.H. Long Professor Emeritus of Internal Medicine
(Endocrinology), developed the insulin infusion pump

for people with diabetes. Stuart Weinzimer, MD,
professor of pediatrics, led a team that produced an
artificial pancreas. And Jonathan Rothberg, PhD ’91,
professor (adjunct) of genetics, developed high-speed
“Next-Gen” DNA sequencing.
Perhaps the most important advance in computerrelated genetics research at Yale came in 2009, when
a research team led by Richard Lifton, MD, PhD, who
was then chair of the Department of Genetics and is
now president of Rockefeller University, used new
technologies to discover the genes and biochemical
mechanisms that cause hypertension. Lifton’s team
developed a technique for performing whole-exome
sequencing, enabling researchers to examine the
protein-coding region of the human genome (about
1% of the whole) at much lower cost than sequencing
the full genome.
Medical technology innovation accelerated after
the Institute of Medicine in 1999 released a report
titled To Err is Human: Building a Safer Health
System, according to Peter Schulam, MD, PhD, chair
of the Department of Urology and chief innovation
and transformation officer for the Yale New Haven
Health System. The report called for technology-based
advances aimed at improving the quality of health care.
Since then, a host of new devices and computer-based
tools have been introduced that enable physicians to
do their jobs better. “Technology has the potential to
minimize human variability and improve patient outcomes,” Schulam says.
Yale is newly committed to playing an even more
prominent role in bringing technology to bear on
humanity’s most critical problems—with medicine
as a top priority. The University Science Strategy
Committee (USSC) last year unveiled a plan to accelerate discoveries, often through multidisciplinary
collaborations. Focus areas in medicine include
neuroscience, inflammation science, conquering cancer, regenerative medicine, and precision medicine.
“A large fraction of the modern frontiers of scientific
and medicine research is interdisciplinary,” says Peter
Schiffer, PhD, vice provost for research. “You’ve got
data people working with fundamental scientists, with
clinicians, and with the engineers designing devices.”
Because data analysis plays an important role in
most of these cross-disciplinary endeavors, Schiffer
is working with leaders of schools and departments
to provide researchers and students with the computational resources they need. Until recently, most
faculty members and programs at Yale purchased

Saquib Lakhani,
Clinical Director
of the Pediatric
Genomics Discovery Program,
is optimistic
that increased
diagnostic capabilities may help
offer treatment
to infants.

and operated their own research computers. But in
2015, the university opened Yale Center for Research
Computing (YCRC), which has five clusters of computers made available to researchers as shared resources.
The YCRC’s computers are housed in a nondescript
former manufacturing building on Yale West Campus.
One of the clusters is dedicated to genetic research.
Named Ruddle (for Francis Ruddle, PhD, a Yale pioneer in genetic engineering), the cluster is made up of
two parallel rows of metal racks containing computers, storage devices, and the networking equipment to
allow them to communicate. Between the racks, it’s
hot and noisy.
Ruddle has roughly the same computational power
as you would get by stringing together 2,000 or so
high-end laptop computers. In addition, it possesses
three petabytes (three quadrillion bytes) of digital
storage. That’s a lot. If you were to fill Ruddle’s storage devices with MP3-encoded songs, you could play
music for 6,000 years.
The reason Ruddle needs so much computing power
sits directly across the street from the data center—
Yale Center for Genome Analysis (YCGA). There,
scientists and technicians use million-dollar genesequencing machines and other tools to help faculty
members and students perform their research. The
gene sequencing takes place at YCGA, while the analysis of the results is done with Ruddle. In some cases,
diseases are caused by variants in multiple genes,
so analysis of the interplay among the genes requires
a large amount of computing power.
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The scale of this type of computation is tremendous. Each individual human genome contains about
3 billion DNA base pairs. It took more than a decade
and about $2.7 billion to sequence the first human
genome—a feat completed in 2003. Now, because of
advances in gene-sequencing techniques and highperformance computing, technicians can sequence and
analyze an entire genome in a couple of days for about
$1,000. Sequencing of the whole exome, which is the
protein coding subset of the genome in which most
disease-causing variants occur, costs about $200 and
can be completed in a few hours.
The PGDP research team uses whole-exome sequencing to make discoveries in such cases as Elsa Violante’s.
Using techniques initially developed by Lifton, a
family’s blood samples are submitted to the YCGA or
another facility like it for sequencing. Next, the computers are used to identify potential variants of interest.
The research team looks at these results, as well as the
specific problems a child has, to find the very best candidates for testing. In the case of Elsa and another child
with similar seizures, variants in the NEUROD2 gene
became the focus.

The PGDP scientists used CRISPR-Cas9 genome editing in frog eggs to explore further. They introduced
CRISPR-Cas9 molecules into the eggs through a tiny
needle. The molecules worked together to target and
eliminate the NEUROD2 sequence. These eggs were
then incubated and tadpoles emerged over the next few
days. Researchers observed the tadpoles’ behavior as
they developed, and they noticed convulsions. Bolstered
with other evidence, they concluded that NEUROD2
variants were the cause of the seizures in both children.
“We hope this discovery helps other children with
infant-onset epilepsy caused by NEUROD2 variants to be
identified sooner, to hopefully have appropriate seizure
treatments sooner,” says Lauren Jeffries, DO, the clinical
genetics coordinator for PGDP. “Having a specific genetic
diagnosis can help doctors and families have better
understanding of treatments, outcomes, and predictions.”
While giving a tour of the YCGA lab, its director,
Shrikant Mane, PhD, professor of genetics, proudly
shows off the latest gene sequencing machines, which
are the size of small refrigerators. Then, with a twinkle
in his eye, he removes a device the size of a smartphone from a box and waves it in the air like a magic

Medical devices and technology
across the years
As long as humans have had the ability to craft tools, they’ve
been using them to solve medical problems. Over time,
the tools have become increasingly complex and sophisticated.
By John Curtis
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wand. “The latest technology that’s on the market—
this is a sequencing machine,” he says.
The device he’s holding is a portable DNA sequencer
developed by Oxford Nanopore Technologies, which
is designed to enable physicians and researchers to
sequence small fragments of DNA or RNA. In one scenario, health workers in Africa could use the device
to test patients in remote villages for Ebola fever. The
sequencer costs just $1,000. “You can carry this in your
backpack. All you need is the human samples and a
laptop. This is the future,” Mane says.
While miniaturization in electronics will make such
devices ever smaller and cheaper, the data sets that
scientists and clinicians work with are getting ever
larger. But that’s a good thing. By combining detailed
genetic information from hundreds of thousands (and
soon millions) of people with data from electronic
medical records and information from research databases, researchers and clinicians can take into account
a wealth of information when they make decisions that
guide research or patient care.
A new initiative at Yale is aimed at rapidly collecting genetic data that can be used for research and care.

6000 BCE
During the Upper
Paleolithic and Mesolithic times, knives,
saws, and drills made
of stones such as
flint are used for
surgery, amputation,
and trepanation.
950 BCE
The world’s oldest
prosthetic devices
are toes for amputees,
made in ancient Egypt
of wood and leather.
300-500 CE
The Greeks and
Romans set the
patterns of modern
surgical instruments
with new tools, often
made of bronze.

1268
It is hard to credit
any single scientist
with the invention
of spectacles, but
Roger Bacon’s studies of optics lead to
development of this
visual breakthrough.
Scholars and monks
had used an early prototype held before
the eyes or balanced
on the nose.
1590
Zacharias Janssen,
a Dutch spectaclemaker, is credited
with the invention
of the compound
microscope, although
controversy remains
regarding this claim.
In 1734, Yale becomes
the first college in
America to obtain
one. More than 50
years later, Yale lists
a microscope as one
of the “machines for a
course in experimental philosophy.”

The Generations Project, launched earlier this year by
Yale Medicine, Yale New Haven Health, and other partners, aims to create a DNA biobank with genetic data
from more than 100,000 people over the next three
to five years. Their genetic data will be linked to their
electronic health records. Participants will have their
genes sequenced and screened for early detection of
diseases and for variants that pose risks. In addition,
the data will be available to researchers performing
broad-based studies.
Electronic health records are essential. Without
the ability to examine an individual patient’s biology
closely and compare what’s happening with that person to what has happened to many others, it’s difficult
to truly understand diseases, to treat patients optimally, and to measure treatment outcomes.
For Harlan Krumholz, MD, the Harold H. Hines,
Jr. Professor of Medicine (Cardiology) and director of
Yale’s Center for Outcomes Research and Evaluation,
all of this new data and computing power is a bonanza.
“In the past, we looked at large averages and said the
results applied to everybody,” he says. “Now, with the
combination of all that data and remarkable computing

1714
Daniel Gabriel Fahrenheit, a DutchGerman-Polish inventor and instrument
maker, invents the
mercury-in-glass
thermometer. The
basic principles of
the thermometer had
been known to Greek
philosophers 2,000
years earlier, while
Galileo had invented
a device to measure
temperature called a
thermoscope in the
late 1603.

1816
A French physician
René Laennec, MD,
invents the stethoscope—originally
a trumpet-shaped
tube—to cover the embarrassment of pressing his ear to the chest
of a female patient.
1851
Hermann von
Helmholtz, a German
physicist, invents the
ophthalmoscope to
examine the retina
and other parts of the
interior of the eye.

1853
Independently of
each other, Charles
Gabriel Pravaz, MD, a
French surgeon, and
Alexander Wood, MD,
a Scottish physician,
develop the hypodermic syringe. The
general principle of
injection had been
known for at least
1800 years—Greek
and Roman physicians
had used thin, hollow
tools known as piston
syringes to inject
fluids into the body.
1895
Wilhelm Conrad
Roentgen, PhD, a
German engineer and
physicist, discovers
X-rays. The first X-ray
images in the United
States were published a month later
by Yale professor
Arthur W. Wright,
PhD and the first clinical X-ray was taken at
Dartmouth College
that same week.
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power at our fingertips, we can make inferences that
are much more focused on individuals.”
Yale New Haven Health is in the process of building a computer system designed to fulfill the promise
of precision medicine. It’s bringing data from many of
its existing computing systems into a centralized “data
lake” where information can be readily accessed and
analyzed. This huge collection of data includes not just
basic electronic health records but also genetic data;
test results from imaging systems and the pathology
department; and real-time data collected from monitoring devices in the intensive care unit.
Krumholz predicts that medicine will be transformed by data within a decade. “We will move from
a place where research and clinical care are separate
domains to one where we learn from every interaction with a patient—it’s built into the system,” he says.
“With every click, the system gets smarter and more
customized. We leverage everything that everyone
has done and is doing.”
It’s not just the amount of data that matters;
it’s also how quickly you can analyze them. Highperformance computers are essential here. Krumholz

1903
Willem Einthoven,
MD, a Dutch physician, refines the
electrocardiogram
developed by a British physiologist and
devises an instrument
to record the heart’s
electrical impulses.
1924
Hans Berger, MD, a
German physiologist
and psychiatrist, expands on Einthoven’s
work and develops a
method for recording
human brain waves
through the skull
known as electroencephalography or EEG.
1929
An American engineer,
Philip Drinker, creates
the iron lung, a device
that breathes for
polio patients who
can no longer breathe
on their own.
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1931
German electrical
engineers Max Knoll
and Ernst Ruska design the first electron
microscope, which
magnifies tiny intracellular structures far
beyond the capacity
of light microscopes.
George E. Palade and
colleagues found the
Section of Cell Biology at Yale in the 1970s,
where they merge
electron microscopy
with biochemistry to
lay the foundation of
modern cell biology.
Palade wins the Nobel
Prize in Medicine or
Physiology in 1964, a
year after his arrival
at Yale.

can imagine a time in the not-too-distant future when
a clinician who is meeting with a patient with complex
health issues will be able to query a computer and get
advice from an artificial intelligence program about a
diagnosis or a personalized treatment plan on the spot—
before the patient leaves the office.
In research settings, this kind of real-time response
is already possible. Nicholas Turk-Browne, PhD ’09, a
professor of psychology and neuroscience, uses highperformance computing along with functional magnetic
resonance imaging (fMRI) to better understand how
the brain works. Measuring brain activity by detecting
changes in blood flow, it correlates activities in various segments of a person’s brain with different kinds
of thinking and emotions. Today, with a collaborative
research team, Turk-Browne is using the system to
train people diagnosed with major depressive disorder
to avoid negative thoughts and feelings. “If we can get
people to change what they’re focusing on, we can avoid
some of the negative symptoms,” he says.
With all of this mingling of medicine and computers, medical researchers and even clinicians are being
asked to develop computer science expertise. Yale’s

1937
The Soviet scientist
Vladimir Demikhov makes the first
artificial heart. It is
transplanted into a
dog, which survives
for two hours after
the surgery.
1943
Willem J. Kolff, MD,
PhD, a Dutch physician invents the artificial kidney, which
evolved into modern
dialysis machines.
1947
John Bardeen, Walter
Brattain, and William
Shockley invent a
semiconductor device
called the transistor at Bell Labs. It
becomes a key piece
of virtually every electronic device, leading
to the development of
medical devices like
cardiac pacemakers.

1949
With dime-store
valves, glass tubing,
and a pump from an
Erector Set, a Yale
surgeon, William
W.L. Glenn, MD, and a
medical student, William Sewell, create an
external heart pump
for $24.80. Yale used
the pump to study
the patterns of coronary blood flow and
devise methods for
its safe removal from
the open heart.

1950
John Hopps, an
electrical engineer, invents the first cardiac
pacemaker. A year
later, Paul Zoll, MD, a
cardiologist in Boston,
is credited with
building on Hopps’
work and developing
an external tabletop
pacemaker for treatment of heart block. In
1959, the first use of a
cardiac radiofrequency pacemaker in the
Western Hemisphere
takes place at Yale
under the direction
of William W.L. Glenn,
MD, chief of cardiovascular surgery.
1957
Edward H. Hon, MD,
and Orvan W. Hess,
MD, publish in Science a description of
an electronic device
to gauge fetal heart
rate. Created by Hess,
with Hon’s assistance,
the device is first
used at Yale New Haven Hospital in 1960.

Center for Research Computing provides tutorials
and training sessions in software coding for faculty
researchers, and graduate programs have been created
to teach data science and bioinformatics.
In the Yale Computational Biology and Bioinformatics
program, doctoral candidates use high-performance
computing to investigate such biomedical questions
as how genes work together at the molecular level
to mediate complex biological processes. William
Meyerson, an MD/PhD candidate in the program, is
studying non-disease-causing mutations—which will
contribute to the understanding of disease-causing
mutations. In his planned career as a physician-bioinformatician, Meyerson wants to facilitate the adoption
of new computer-aided decision-making tools. “There
are language and culture differences between doctors
and computing experts,” he says. “My role will be to
bridge the gap between my computational colleagues
and my clinical colleagues.”
While many of the innovations that drive progress
in medicine take place within the walls of medical
schools, much of the discovery in the realm of medical technology happens in the wilds of the business

1960
Theodore H. Maiman,
PhD, operates the first
optical laser at Hughes
Research Laboratories
in California. Lasers
have many uses in
medicine, including
surgery, kidney stone
treatment, ophthalmoscopy, and cosmetic
skin treatments.
1970s
Computer technology begins to merge
with medical technology; it is now used to
store medical records,
control instruments,
and perform robotic
surgery.

1971
Paul Lauterbur, PhD,
applies magnetic field
gradients to create
nuclear magnetic resonance (NMR) images.
Along with physicist
Peter Mansfield, PhD,
he develops MRI techniques like echo-planar
imaging. In 1979, with
the arrival of Robert
G. Shulman, PhD, Yale
becomes a leader in
magnetic resonance
research, and Yale faculty are the first to use
MRI to measure the
brain’s performance of
cognitive tasks.
1974
Raymond Damadian,
MD, is granted the
world’s first patent
in the field of MRI,
after he discovers
how to use magnetic
resonance imaging
for medical diagnosis.
By 1977, Damadian
completes construction of the
first whole-body
MRI scanner.

world. That’s why we increasingly see faculty members who have one foot planted in academia and the
other in commerce.
Jonathan Rothberg, the gene sequencing innovator,
shows how this two-step is done. While he remains
on the adjunct faculty at Yale, his day job is running
a startup incubator based in nearby Guilford, where
seven companies so far are targeting health care. In all
cases, they’re developing medical devices that use deep
learning, a form of artificial intelligence, to continually improve their performance. One of his companies,
Butterfly Network, developed a handheld ultrasound
device that costs less than $2,000.
Rothberg predicts that the combination of technology
and medicine will have profound effects on the future
of the human race—for instance, he believes that people
will someday live to be 200 years old. “We have sequencing, we have medical records, we have high-performance
computing, and we have AI,” he says. “We’ll understand
the complex diseases, and we’ll be able to intervene and
extend life.” /yale medicine magazine
Steve Hamm is a frequent contributor to Yale Medicine Magazine.

1975
Robert S. Ledley, MS,
DDS, a physiologist, radiologist, and
biophysicist, invents
whole-body computed tomography
(CT) scans. His device
builds on early designs by Sir Godfrey
N. Hounsfield, a British electrical engineer,
who developed the
computerized axial
tomography (CAT)
scanner, which combines cross-sectional
X-rays taken at different angles around
the body.

1978
Yale researchers William V. Tamborlane,
MD, professor of
pediatrics, and Robert S. Sherwin, MD,
professor of medicine,
develop the insulin
infusion pump for
people with diabetes.
The pump provides a
means of maintaining
better control over insulin levels in children
who would otherwise need multiple
daily injections.

2015
Stuart Weinzimer, MD,
and colleagues at Yale
are at the forefront
of efforts around the
country to develop an
artificial pancreas. The
closed loop system of
devices and software
transmits blood glucose level readings to
a device that controls
insulin delivery.

1982
The first permanent
artificial heart is implanted at the University of Utah. Until then
artificial hearts had
served as a bridge to
transplantation. The
heart was developed
by Robert K. Jarvik,
MD, who modified
earlier models and on
December 2, implants
an artificial heart into
retired dentist Barney
Clark, who survives for
112 days.
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Building lung
capacity, lung-first
jenny blair, md ’04 | robert lisak photo

The disembodied living lungs in one Yale researcher’s
lab show that a standalone bioengineered lung is
well along the road to reality.
Pneumonia, aspiration, fluid in the lungs, and injuries
from mechanical ventilators can severely damage the
lungs of people who are critically ill. Transplanted
lungs are tragically scarce and beyond the reach of
most such patients, including those burdened by such
chronic lung diseases as cystic fibrosis or emphysema.
What if custom-grown new lungs were an option?
The idea sounds like science fiction. But the disembodied living lungs in one Yale researcher’s lab
show that a bioengineered organ is well along the
road to reality.
“It’s an exciting time to be working in lung regeneration,” says Laura Niklason, MD, PhD, the Nicholas
M. Greene Professor of Anesthesiology and professor of
biomedical engineering.
“Our understanding of how the lung is put together
is growing very rapidly right now.”
Trained as an anesthesiologist as well as a bench scientist, Niklason spent years in the ICU witnessing the
devastating results of lung infection and damage. “Many
organs heal, but after severe injury, lungs tend not to,”
she says. When she arrived at Yale in 2006, she began
working on lung regeneration; the possibility seemed
even more far-fetched then than it does now.
Four years later, her team transplanted a regenerated lung into a rat; it performed effective gas
exchange, albeit briefly. The achievement made it into
the pages of Science in June 2010.
There are not nearly enough transplantable lungs
available for the people who need them. Only about
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15% of cadaveric donors provide useable lungs, in
part because many patients linger on ventilators and
accumulate lung damage, including infections, prior
to death. (Contrast that with the 88% harvest rate for
cadaveric kidneys.) Lungs also don’t take kindly to
transport and typically have to be transplanted within
a few hours of harvest.
In addition to the tight supply problem, lung transplant recipients face a lifetime of immunosuppressive drugs to prevent their bodies from rejecting the
donor lungs. A lung engineered from the patient’s own
cells could circumvent the immune system and spare
patients the risks of long-term immunosuppression.
Fortunately, the lung makes for a more feasible bioengineering challenge than does a solid organ like a
kidney or heart. The lung is mostly empty space, comprising a protein skeleton coated with thin cell layers
that exchange oxygen and carbon dioxide.
The first step to building a new lung is to partially
dismantle an existing one. Niklason’s team has developed a reliable method using detergents, salts, and
enzyme solutions to remove the cells from an adult
lung. Leaving that skeleton and its dozens of attached
protein types intact is crucial. These proteins vary
from one part of the lung to another, and they send
signals that direct what kind of cells a progenitor cell
landing on them will become.
The second lung-regeneration step is to wash the
protein skeleton with hundreds of millions of new cells
that lay down fresh airways and blood vessel linings.

Medically viable
lungs are difficult
to come by, and
eagerly awaited
by many suffering from conditions like cystic
fibrosis. Bioengineered organs
like this mouse
lung represent a
hopeful promise
for patients.

If step one has left the proteins intact, the cells should
in theory find their way to the right place.
“There are zip codes that are built into the matrix of
the lung,” says Micha Sam Raredon, an MD/PhD candidate in Niklason’s lab. “If you seed a homogenous set
of cells … depending on where they fall on the scaffold,
they’re going to get site-specific cues that can push
them toward a certain phenotype.”
“Getting the cells there, physically getting them
there, is much easier. Getting them to behave and to
do what you want them to do—that’s the tricky part,”
Niklason says.
The new lung grows in a glass jar that bristles with
tubes and connectors. Custom-made by the university’s in-house glassblowing team, these so-called bioreactors suspend the growing lungs amid fluid that flows
rhythmically around them. One set of tubes pumps the
fluid through the lung vasculature as the heart would;
another carries fluid away to be oxygenated as it would
be by a placenta.

“Proper breathing motion is certainly critical for actually getting our lungs to form and getting the cells to
differentiate the way they should,” Niklason says. “We’re
mimicking the embryonic state of lung development.”
“It looks exactly like what you’re picturing,”
Raredon adds. “They’re these pulsing organs in a glass
jar that we’re keeping alive.”
When might patients with devastating lung diseases
have access to brand-new lungs of their own? A firstin-humans implant could happen within 15 to 20 years,
Niklason estimates. “It’s a hard problem and it’s a
several-decade problem, and you need a lot of people
and a lot of resources to try to tackle it,” she says.
“I tell everybody, ‘I hope to do this before I die.’” /yale
medicine magazine
Jenny Blair is a frequent contributor to Yale Medicine Magazine.
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A perfect day
for a zebrafish
by amanda m. dettmer, phd | robert lisak photo
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Ellen Hoffman
has designed
experiments that
may provide insights about autism and epilepsy
in humans. Using
an advanced microscope built by
Joel Greenwood,
director of the
neurotechnology core in the
Kavli Institute
for Neuroscience,
she will be able to
study zebrafish
brain activity
at a previously
unattainable
resolution.
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A perfect day for a zebrafish

Ellen Hoffman is developing a microscope that
will enable her to look into zebrafishes’ brains.
On a warm sunny morning last September, eight 4and 5-year-olds in Phyllis Bodel Childcare Center’s
kindergarten class on the campus of Yale School of
Medicine (YSM) sat outside at picnic tables with their
eyes glued skyward. In the middle of the courtyard in
front of them a large crane was slowly lifting enormous
crates from a giant delivery pallet to a doorway in
the Sterling Hall of Medicine. For over an hour, these
youngsters sat nearly still with razor-like focus on the
large machinery, discussing what was happening—and
what was inside those crates.
The enormous crane was unloading parts of a
microscope into YSM, one that would be built by
Joel Greenwood, PhD, associate research scientist in
neuroscience and director of the Neurotechnology Core
in YSM’s Kavli Institute for Neuroscience. Greenwood
established the core in 2017, a design and fabrication
facility that is free for other researchers to use. At the
same time, Greenwood had just started to construct
another microscope, one that also required special
delivery of multiple component parts, a two-photon
laser, and rigging for a large optical table. This microscope was being built from scratch, and is the only one
of its kind in New England.
The gargantuan microscope that’s being built? One
dedicated to the study of tiny organisms—zebrafish.
Ellen Hoffman, MD, PhD ’14, assistant professor in the
Child Study Center and of neuroscience at YSM, will
use this microscope to perform whole-brain functional
imaging in zebrafish to better understand the function
of genes that increase the risk of autism. This microscope will enable her to look into the fishes’ brains
throughout development—their embryos are transparent—to examine brain structure in zebrafish lacking
functional autism risk genes. Using this specialized
microscope, Hoffman will be able to collect live images
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of the fish while watching neural signaling before,
during, and after drug treatment. In this way, she will
be able to glean information that wasn’t possible before
she acquired this microscope.
“This microscope will enable us to visualize how loss
of function of autism risk genes leads to differences in
neural signaling in the developing vertebrate brain in
real time at the single-cell level,” says Hoffman.
As with other colleagues at YSM, Greenwood is
teaching members of Hoffman’s lab to build and use
components of the microscope while providing crucial
oversight in the process. In this way, scientists will
have an intricate understanding of this specialized
piece of technology. This understanding also helps scientists think critically about their work and the specifics of how experiments can and should be conducted,
Greenwood says.
This microscope had to overcome a primary challenge of working with zebrafish—how to record the
animal quickly and without its knowing. Hoffman’s
microscope is a two-photon light sheet microscope,
meaning that sheets of light rapidly “scan” through
the entire fish brain to record whole-brain activity in
less than one second. Traditional two-photon microscopes are slow, scanning the brain point by point.
With a small zebrafish, the animal must be held still in
a natural position and scanned quickly enough that it
can’t detect the light. Otherwise, its natural behaviors
would be compromised.
To solve this problem, Hoffman and Greenwood
relied on existing research publications to build
the novel instrument that will precisely answer
Hoffman’s questions. They modified attributes of
existing models to make her microscope a “double
whammy”—one that increases the speed of the light
sheet and is also invisible to the fish. The two-photon

David Jin, graduate student in the
Interdepartmental Neuroscience
Program, and
Tianying Chen,
MS, research
assistant, work
in the laboratory
of Ellen Hoffman,
MD, PhD, which
is part of the
Neurogenetics
Program at the
Yale Child Study
Center, and is
involved in translational research
on the genetics of
autism spectrum
disorders.

light sheets are outside the visual spectrum of the fish,
making the light undetectable to the animal, and the
light can penetrate deeper, giving better resolution.
The microscope will enable Hoffman and her team to
see more neurons simultaneously in a live, functioning animal. This clarity will give her studies both
ethological and ecological relevance.
Hoffman already knows the first experiments she
will conduct with this microscope, which was funded
by the National Genetics Foundation, the SPECTOR
Fund, the Kavli Foundation, and the National
Institute of Mental Health. She plans to study baseline brain activity in fish that have mutant forms of
the CNTNAP2 gene, which is strongly associated with
autism and epilepsy in humans. Using transgenic fish
expressing a form of green fluorescent protein that
turns on when brain cells become active, Hoffman
will learn what is happening at the cellular level. She
then hopes to determine how compounds identified
in related drug screening experiments affect brain
signaling. For these studies, she will be able to use her

new microscope to understand how changes occurring at the circuit level in the zebrafishes’ brains
might relate to behavioral differences resulting from
loss of autism risk gene function.
With this new technology, Hoffman aims to answer
fundamental questions about the mechanisms underlying brain and behavioral development so she can lay the
groundwork for developing improved treatments for
children with developmental disabilities. In so doing,
she may also lay the groundwork for a future scientist—perhaps even one of the children admiring how
carefully the crane’s long arm moved microscope parts
into YSM—to develop the next generation of technologies to make life-altering discoveries. /yale medicine
magazine
Amanda Dettmer, is an associate research scientist in the Yale Child
Study Center and a contributor to Yale Medicine Magazine.
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Where scientists and
entrepreneurs mingle
by jeanna lucci-canapari | matthew daley illustration

The Center for Biomedical Innovation and Technology provides
a home for those who want to develop medical devices to meet
unmet needs in health care, and bring them to patients.
Have an idea to develop a novel biomedical device,
diagnostic, or health IT app that could have big patient
impact? There’s a place where scientists, clinicians,
and entrepreneurs can connect at Yale’s Center for
Biomedical Innovation and Technology (CBIT).
During the past five years, CBIT has developed into
a one-stop shop for would-be biomedical innovators
and entrepreneurs. To date, CBIT has supported more
than 3,000 members of the Yale community and over
200 projects that have attracted more than $24 million
in outside funding.
“Yale is about getting good ideas out into the world,”
says CBIT co-founder Mark Saltzman, PhD, Goizueta
Foundation Professor of Biomedical and Chemical
Engineering. “Entrepreneurship is another way to do
that, and to make an impact.” He and Peter Schulam,
MD, PhD, professor and chair of the Department of
Urology, founded CBIT in 2014 in response to a cultural
shift they saw happening in higher education. “Starting
your own company directly out of school has become a
more common career pathway,” says Saltzman. “There
is a lot of interest, but how do you get there?”
“When Mark and I co-founded CBIT, the idea was to
more comprehensively support not only medical device
development in this community, but also health IT,
diagnostics, and processes,” says Schulam. CBIT collaborates with the Office of Cooperative Research,
which supports faculty and researchers in developing technology of all types. Saltzman and Schulam
wanted to expand the support and expertise offered

for biomedical innovation. “CBIT team members have
multiple roles,” Schulam says. “We educate and build
culture. We provide mentorship, and help innovators
successfully obtain seed funding.”
To help innovators, CBIT centers its services around
four fundamental domains of biomedical design,
according to Schulam. These include the technical,
clinical, regulatory, and business aspects of innovation.
Setting milestones that address all four of these needs
isn’t always intuitive to science professionals who are
unfamiliar with venture creation.
“Often our innovators have a technical or clinical
background, so they are inclined to move their innovation all the way to the end from a technical perspective.
CBIT works with them to make sure they are addressing the appropriate clinical, market, and regulatory
issues as they evolve the technology,” says CBIT’s
Innovation Director Margaret Cartiera, PhD ’07.
“You have to understand the process if you are in
the device or health IT world and you have an idea,”
adds Schulam. “At each step, you have to ask yourself
whether you are meeting those four areas. If you are
not, you have to pivot or you will end up with something that is not marketable.”
Through formal coursework, informal mentoring,
and campus activities like hackathons, students and
faculty can explore innovation in the health care space
“with guardrails or without,” says Cartiera. A variety of
partnerships within the university and beyond keeps
innovators on the path to success.
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For one-on-one mentoring, CBIT looks to industry
to match innovators with experienced entrepreneurs.
Co-Executive Director Michael Dempsey, having built
three medical device companies, brings that perspective to CBIT.
“We work with the investigator on market analysis,
while we simultaneously teach the investigator how to
do it,” Dempsey says. “CBIT’s whole notion of mentoring is pretty intimate. You have to find the right combination of people who will spend a lot of time together
to make the project successful.”
Before he became co-executive director of CBIT,
Chris Loose, who has a PhD in chemical engineering from MIT, had launched a successful biomedical
venture of his own. At Yale, “I was eager to help students and faculty do the same,” he says. “One of the
real powers of CBIT is that we put MDs with business
students with undergrads and others to create highly
diverse collaborations that are critical for innovation.” This collaboration extends to formal coursework
offered by CBIT. Loose teaches a course called Creating
Health Care Ventures, in which students from across
Yale work on building business and product plans.
Another well-attended course, Medical Device
Design and Innovation, is co-sponsored by one of
CBIT’s crucial partners, the Center for Engineering
Innovation and Design, which also works with CBIT to
build prototypes of the medical devices created.
CBIT also holds an annual hackathon, in which
teams examine unmet medical needs and connect with
experienced entrepreneurs, care providers, administrators, and others capable of coaching them toward
generating new solutions. “We bring hundreds of
people together across dozens of institutions, including
internationally,” says Loose. To date, CBIT has organized six hackathons around campus.
CBIT also develops funding sources for biomedical innovations. The group worked with the state of
Connecticut to create Bio Pipeline CT, a collaboration
with Yale, the University of Connecticut, Quinnipiac
University, and the Connecticut Innovations agency
which administers the Connecticut Bioscience
Innovation Fund. CBIT founded a $1 million, twoyear initiative that provides groups of faculty and
students, or small start-up companies affiliated with
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any Connecticut university, with up to $30,000 per
project of gap funding. For every dollar given, says
Loose, “$14 in follow-on funding was raised by these
companies supported by the Bio Pipeline to continue
to advance their ideas, and four have gone to human
trials.” The program has just been renewed for another
$1 million, two-year round of funding.
Saltzman’s own project was one of the first to be
funded by the Bio Pipeline. For guidance, Saltzman
and his colleague, Michael Girardi, MD ’92, professor
of dermatology, turned to fellow experts at CBIT. They
developed a biodegradable bioadhesive sunscreen using
nanoparticle technology that does not absorb into the
skin, unlike most commercially available sunscreens
that may cause potentially harmful side effects. “We
have a start-up company now that is going to put it
into production, and hopefully into bottles and onto
shelves,” Saltzman says.
Now that the appetite for entrepreneurship has
taken hold, the next step for CBIT is to continue
building collaborations with campus organizations.
“CBIT is docking into Tsai CITY,” says Schulam. Tsai
CITY (Center for Innovative Thinking at Yale), where
Schulam acts as faculty director, operates as a portal
and connector for organizations such as CBIT across
the university. “CBIT is one component within a larger
ecosystem of innovation,” he says. “Through Tsai CITY,
we are creating interconnectivity, collaboration, and a
multidisciplinary approach to innovation.”
Because of CBIT’s success on campus and in the
world beyond Yale, the idea and process remain at the
heart of its mission. “We want our community to know
that if you see an unmet clinical need and you have an
idea, you should run with that idea. The exploration
itself is useful, even if it doesn’t end in a company,”
says Schulam. /yale medicine magazine
Jeanna Lucci-Canapari is a frequent contributor to Yale Medicine
Magazine.

The new ultrasound devices
in Yale School
of Medicine’s
clinical training
rooms will give
students an
advantage when
it comes
to developing
the diagnostic
skills necessary
to be effective
physicians.

Honing clinical skills
with ultrasound
by abby roth | harold shapiro photo
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Honing clinical skills with ultrasound

Ultrasound augments learning opportunities for
medical students.
In January 2019, Yale School of Medicine (YSM) completed a renovation project that included 14 new clinical training rooms equipped with ultrasound tablet
devices. This technology did not exist in the former
practice space and its addition has already had positive
results for medical education.
These changes are particularly evident in the
Clinical Skills Course, which spans the first 18 months
for all medical students. In it, students learn how to
communicate with and examine patients and develop
their clinical reasoning skills.
Jaideep Talwalkar, MD, associate professor of medicine and of pediatrics and director of clinical skills
explains, “The Clinical Skills Course has always been
hands-on, but what is novel about using ultrasound
is the added layer of visualization in real time that
ultrasound provides, simultaneous with other learning
modalities that we’ve already been using.”
Rachel Liu, MBBCh, assistant professor of emergency medicine and director of point-of-care ultrasound education, is excited about the educational
opportunities the renovation makes possible.
Liu introduced point-of-care ultrasound into the
longitudinal preclerkship curriculum six years ago
with a pilot program converted into a preclerkship
elective. She believes point-of-care ultrasound’s
central mission is to aid students in understanding
how to integrate anatomy, physiology, and pathology while learning physical examination skills. This
approach is different from ultrasound as a diagnostic
tool that may be introduced in fourth-year electives,
residency, and fellowship training. “Point-of-care
ultrasound holds distinct roles in both education
and patient care, but it is not a replacement for
imaging performed by radiologists or other medical
specialists,” Liu says.
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When Liu developed the preclerkship pilot, she combed
the YSM curriculum to pair it with ultrasound uses. She
then worked with Talwalkar and Joseph Donroe, MD,
MPH, assistant professor of medicine and director of physical examination education, to bring ultrasound into the
Clinical Skills Course. Donroe, who teaches small groups
in Liu’s curriculum, provides examples of how ultrasound
is enabling him and his colleagues to better instruct students in the art of physical examination.
In the past, faculty would have students practice palpating the abdomen to look for the liver, but it was often
difficult for students to understand exactly what they
were touching. Now, by coupling the physical exam with
ultrasound, students can literally see the liver, making
the experience more concrete and memorable. A similar
effect is achieved when students can see heart valves
opening and closing in real time using ultrasound as they
listen to a heartbeat with a stethoscope.
Elizabeth Woo, a third-year MD/PhD student, is
grateful to have been in the ultrasound longitudinal
course. She describes how during her preclerkship
years, ultrasound “allowed me to better contextualize
human anatomy as well as seeing the ‘why’ to different
clinical maneuvers.”
Second-year medical student Pablo Delis, who is taking the ultrasound elective, echoes Woo’s praise for the
course. “Being able to see a heart beating, bowel peristalsing, and lung pleura sliding in real time has been invaluable in solidifying my understanding of these organs.
Knowing I am competent in performing essential ultrasound studies and interpreting the images taken by other
medical team members has granted me a level of confidence I believe is rare among first-year medical students.”
With the new space and equipment, students can
now practice ultrasound in small groups. This opportunity will make it easier for students to develop their

skills and take advantage of peer-to-peer teaching.
Such shared learning had not been possible previously
when students used vendor-loaned equipment at various locations.
Sixteen first-year students and seven second-year
students who participated in the longitudinal ultrasound elective have been certified to help train peers.
Michael Schwartz, PhD, associate professor of neuroscience and associate dean for curriculum, believes
this peer-to-peer training aids students’ development.
Students and faculty are enthusiastic about integrating ultrasound into the medical education curriculum, does it actually improve learning? Liu, Donroe,
and Chris Moore, MD, associate professor of emergency
medicine and section chief of emergency ultrasound,
are conducting research to find out. Most studies
involve tests specific to ultrasound teaching. However,
Liu says, “nothing has really looked at the effect of
ultrasound teaching to the more general curriculum,
and this is the part that is important.”
In her research to date, Liu looked at students’
qualifying examinations and the examinations that all
students in every medical school must pass (objective
structured clinical examinations or OSCEs, and United
States Medical Licensing Examinations or USMLEs).
“Overall we found that the area where ultrasound
teaching seemed to have a beneficial statistical significance was in the physical examination performance
of their OSCE.” These findings are limited by a small
sample size. The YSM curriculum changed in 2015, and
Liu was able to obtain only two years of data from the
old curriculum. She plans to repeat the study, as she
will soon have access to up to four years of data from
the new YSM curriculum.
Evidence that the ultrasound device is enhancing education is critical. As Schwartz says, “If two
years later we are talking about the technology of
ultrasound, we have missed the boat. The key is not a
technological tour de force; it is how the technology
enhances education.”
Liu says that when the Department of Emergency
Medicine offers point-of-care ultrasound training courses to faculty, “we routinely have attendees
from many different specialties.” Both Talwalkar and
Donroe attended these courses. Before his initial training, Talwalkar spent a month-long sabbatical in late
2018 in Santiago, Chile, with Liu’s colleague, Pablo
Aguilera, MD, Chief of Emergency Medicine, Pontificia
Universidad Católica de Chile. Talwalkar’s main goal
was to learn the basics of ultrasound because, as he

explains, he has been helping “to build ultrasound into
the YSM clinical skills curriculum, but had absolutely
no ability to help out with the teaching. I was more
novice than the students.”
Like Talwalkar, many YSM doctors and residents
are new to point-of-care ultrasound and eager for
training because the technology’s widespread use is a
fairly recent development. Since returning from Chile,
Talwalkar has used ultrasound in clinic and on hospital
rounds to highlight its uses with residents and students. He says, “Learners are extremely enthusiastic
about using it. They recognize the potential applications, but many residents have had little exposure.”
Ultrasound training is standard in such residencies as emergency medicine, obstetrics, and radiology,
but other specialties are just starting to incorporate it
into their training. Liu plans to collaborate with YSM’s
Teaching and Learning Center to create more faculty
development opportunities to train future educators.
Gail D’Onofrio, MD, MS, chair and professor of emergency medicine, reflects on the critical role of ultrasound in emergency medicine and as an educational
tool. “Ultrasound has become an essential tool in the
ED as we evaluate patients with acute life-threatening
illnesses and injuries. Dr. Liu is a remarkable trailblazer
in educating students, residents, and faculty in the skill
of ultrasound. Her passion, expertise, and creativity
are apparent in her teaching. She is world-renowned
for helping to create the innovative SonoGames® and
SonoSlam™ as pedagogical exercises. We are incredibly fortunate to have her here at Yale.” /yale medicine
magazine
Abby Roth is a communications officer in the Office of Education and
a contributor to Yale Medicine Magazine.
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Engineering Innovation
by ken byron | harold shapiro photos
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Engineering innovation

Yale School of Engineering and Applied Science
combines medicine, engineering, and
problem-solving to increase the reliability
of orthopaedic devices.
Maddy O’Neal held a shiny titanium screw in her hand
while studying a computer model of the device on the
screen in front of her, looking for potential weaknesses
once the screw is put in someone’s body to repair a
broken hip. “There are lots of ways these can fail,” says
O’Neal, a senior majoring in biomedical engineering.
“The screws can come out and float around in someone’s body. There are a lot of moving parts, which is a
good thing and a bad thing.”
The device O’Neal is evaluating is one of several
types designed to help mend broken hips that have one
feature in common—a history of breaking. Improving
those flawed devices is a challenge that O’Neal and
her classmates have attempted to resolve this semester. O’Neal is among 20 undergraduate students in the
medical device design class, which is offered by Yale
School of Engineering and Applied Science. The course
combines medicine, engineering, and problem-solving
with the goal of improving unreliable devices.
Broken screws are a problem. In the case of one
model, the shaft that runs along the femur can fail
where the bone is broken. The bone is not supporting
the patient’s weight at that point—the metal shaft must
do it. Sometimes the shaft is not up to the task, says
Alexander Crich, a senior majoring in biomedical engineering and mechanical engineering, as he held the
implant in front of him.
Students do much of their work with computer
modeling software, but real-world experiences are an
important part of the class. Accompanying one of the
course directors, Daniel Wiznia, MD, in the operating
room, students get a sense of the surgery in which the
implants and screws are installed.
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Another lecture features a presentation from
Kristaps J. Keggi, MD ’59. A professor emeritus and
senior research scientist of orthopaedics and rehabilitation in the medical school, Keggi has performed over
ten thousand hip-replacement surgeries and consulted
for companies that produce the implants. He told students the work they are doing has been going on since
the 19th century, when early implants were made of
ivory or wood. Keggi told students that physicians
have played a key role in improving implants. While
the students are using sophisticated computer software
for their projects, Keggi says he once sketched the preliminary design for an implant on a napkin in a restaurant while on a business trip in Cleveland.
“We learned as we were using them,” Keggi says of
the implants.
This is the fifth year the engineering school has
offered the medical device design class. In previous
years, students were asked to come up with an
idea for a new device. Proposals included a lab coat
sanitizer and technology aimed at helping people
recover from concussions.
Steven Tommasini, PhD, a research scientist of
orthopaedic rehabilitation at Yale School of Medicine
who is co-teaching this semester’s class, says that
this year students are focused on improving existing
devices. Hip implants were chosen because procedures
for that part of the body are common, Tommasini says.
“Compared to other implants they are relatively simple.
Also, they are in a spot that is the most heavily loaded
spot in the body, so failure is not uncommon,” he says.
Students are divided into teams charged with
studying one of five different implants used to treat

hip fractures. Each of these devices is on the market,
but they have unique strengths and weaknesses for
treating different fracture patterns, Tommasini says.
The students use computer modeling to simulate the
stresses on each implant to figure out where and how it
fails. With that information, they can turn their attention to designing a better implant.
After studying the hip screws, the students model
different kinds of artificial hip joints used for total
replacement procedures. After that, they can choose
their own idea for the final part of the class, Tommasini
says. He teaches the class with Wiznia, who is an assistant professor of orthopaedics at the medical school as
well as an assistant professor of mechanical engineering
and materials science at Yale School of Engineering.
Wiznia says students are studying how well these
hip implants treat an uncommon injury called a subtrochanteric fracture. This kind of fracture can result from
an accident but is also seen in patients taking bisphosphonate therapy for osteoporosis. Although the implants
are customarily used to fix this kind of fracture, Wiznia
says that the implants were not designed for it. “They do
an okay job, but they have a failure rate.”
The class was not going to be held in the spring
semester because of a scheduling conflict but was
put on the schedule anyway after widespread student demand. “I was excited to take a class where you
design something, get your hands dirty, and solve a
problem,” says Matan Cutler, a sophomore.
“They needed someone to take over this class
and we’re hoping we can keep doing it because we’re
having fun,” Tommasini says. “This is one of the few
classes where you get to build something and be creative. Engineering students don’t get to do that a lot.”
Wiznia says the class is a good way of bringing
together two disciplines that can help each other.
“As an engineer, you are a problem solver,” he says. “As
a surgeon, you are constantly trying to improve medical outcomes. This is a terrific fit for an engineer.”
Most of the students who take the class are in the
engineering department. Lauren Ribordy, a senior
majoring in biomedical engineering, says she was
excited to use the computer modeling technology but
also found it sobering to find out more about bone
fractures. “There is a lot of potential to help people,”
Ribordy says. “It should not be a case of ‘We hope it
will work.’ Can we model it to see if it will fail before
we give it to a patient?”
O’Neal says she wants to go into the medical field
and work with implants. Initially she was interested

PREVIOUS SPREAD, LEFT

Students from the engineering
school’s medical device design
class examine an implant designed
to treat hip fractures. The curriculum emphasizes out-of-the box
problem solving for rare injuries for
which there is no financial incentive to develop new products.
Clockwise from top left: Sofia Griff;
Sofia Griff (L) and Matan Cutler
(R); Maddy O’Neal (L) and Fadzai
Mataru (R); Sofia Griff (L), Dan
Wiznia (M), and Matan Cutler (R);
Lauren Ribordy (L) and Steven
Tommasini (R); Steven Tommasini.
.
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Daniel Wiznia, one of the class’s
two instructors and faculty at Yale
School of Medicine (YSM), discusses one of the challenges facing
designers when it comes to im-

proving medical devices with student Alex Critch. Wiznia graduated
Yale with a degree in Mechanical
Engineering in 2006, and it remains
an important component of how
he views medicine at YSM.
ABOVE The last hundred years or

so saw huge jumps with innovation as materials research made
durable equipment more accessible and easily produced. Since
that time, advances in ceramics
and 3D printing technologies
have made it possible to improve
devices. This hip screw, or “sliding”
hip screw, originated in the 1960s
and still has excellent outcomes in
most cases.

in prosthetics but shifted her interest to hip devices,
in part because of the experience of her grandmother
who, she says, had both knees and a hip replaced.
She also sees a growing need for better technology to
repair joints.
“This is really what I want to do, implants or something like that. They are so cool,” O’Neal says. “As people
get older our bodies are more likely to fracture; and
now athletes are getting knee replacements that need to
stay in place for 30 or 40 years. With people living longer, implants won’t be going anywhere.” /yale medicine
magazine
Ken Byron is a contributor to Yale Medicine Magazine.
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When skin-deep is
all you need
by christopher hoffman | matthew daley illustration

Working with faculty at Yale School of Medicine’s
Department of Dermatology, two Yale undergrads
built a device that’s helping doctors diagnose
skin conditions from afar.
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Elizabeth Asai, Yale College ’13, never dreamed she
would one day co-found and run her own company.
To her, entrepreneurship seemed too chaotic a way to
make a living. “I thought I’d go to medical school or
work for a larger tech company,” Asai says.
Fate intervened in 2011 when Asai and fellow Yale
undergrad Elliot Swart entered a Boston-based student
contest to build a primary-care medical device. The
contest offered large cash prizes so winners could turn
their prototypes into marketable products.
Before the contest, the pair—Asai was a biomedical engineering student, Swart was studying electrical
engineering and computer science—had been working
on what they now acknowledge was an overly ambitious project. They were trying to develop a probe that
used 3D imaging technology to assess the texture and
elasticity of such internal tissues as tumors.
Realizing their product would not fit the primarycare focus of the contest, Swart and Asai shifted gears.
They decided to use knowledge they’d acquired in their
first project to create a new, simpler device that took
3D pictures of skin to assist dermatology diagnoses.
Asai and Swart’s instincts proved spot on—their
new device won second prize and $100,000. Key to
the pair’s second-place finish was assistance from
Yale School of Medicine’s Department of Dermatology.
Doctors there fast-tracked a clinical study of the product involving 50 patients, producing results in just four
months, Asai says. The 30-page writeup documented
that their product works—a vital piece of their contest
submission, Asai says.
Swart and Asai used the money to further develop
their idea. The next year they founded a company they
dubbed 3Derm Systems, evoking the firm’s combination of 3D imaging and dermatology.
Seven years later, 3Derm is thriving. The Bostonbased company has a network of over 250 primary-care
physicians using its 3D imaging and telemedicine products, Asai says. She is the company’s CEO, while Swart
is its chief technology officer. The pair, now both 27,
express deep satisfaction with the company’s success.
“I can definitely say it’s been a rewarding experience
taking a product all the way through its life cycle, from
its inception and experimentation, to commercialization and getting to see patients use it,” says Swart, who
got so involved in the firm that he left Yale shortly
before finishing his degree. “I think it was more
rewarding to me than I would have anticipated.”
Yale was “very important” to their success,
Asai says. In addition to early encouragement and

assistance from the engineering department and Yale
School of Medicine, the school also helped with the
business side. “We knew the engineering and clinical
needs,” Asai says. “But we really didn’t know how to
pair that with a business model.”
Yale Entrepreneurial Institute paired them with an
experienced serial entrepreneur who provided a crash
course in business. He also introduced them to Blue
Cross Blue Shield, which became and remains their
biggest investor.
Over time, 3Derm’s product has evolved from
straight 3D imaging of skin into a cloud-based dermatology platform, Swart says. Doctors who sign up
receive one of the firm’s proprietary 3D cameras. When
they see a problematic lesion or skin condition, they
take a photo that is uploaded into the cloud, Asai says.
Dermatologists chosen by the primary-care offices
then examine the cases remotely to determine whether
the patient needs to be seen in person.
“This is not dermatology in a box, where we have a
room full of dermatologists reading cases all day,” Asai
says. “All of the dermatologists we work with are out
seeing patients in person.”
The company guarantees an answer within 72 hours,
but typically provides one in 12 hours, she says. That’s
much faster than scheduling appointments with dermatologists, who have wait times as long as 100 days.
It also saves money because dermatologists conclude in
54% of cases that the patient can be treated in primary
care, eliminating the need for an office visit. And when
a skin issue is flagged, diagnosis and treatment can
arrive faster, saving money and lives.
3Derm may have come a long way, but it is just getting started, Asai says. The firm is hard at work developing algorithms with diagnostic and triage functions,
avoiding the need for referrals. One algorithm would
help manage psoriasis, while the other will do the
same for skin lesions. The firm expects to deploy one of
the systems in the near future, Asai says.
3Derm remains privately held with no near-term
plans to go public. Even discussing such a development
is premature. “I think it is far enough in the future that
we laugh when we hear that question,” she says. /yale
medicine magazine
Christopher Hoffman is a frequent contributor to Yale Medicine
Magazine.
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Scratching the surface:
Metallic glass implants
jenny blair, md ’04 | harold shapiro photo
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Jan Schroers, a
professor of
mechanical
engineering and
materials science
at Yale, believes
that devices
fashioned from a
new class of biomaterials called
metallic glasses
could vastly improve outcomes
for patients who
need surgical
implants.
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Scratching the surface: Metallic glass implants

A class of biomaterials called bulk metallic glasses
could transform future implanted medical devices and
other engineered objects.
Artificial joints, blood-vessel stents, bone screws,
and other implanted objects—crucial tools to help
patients—carry risks related to the materials they’re
made of. Valves and stents, for example, can provoke
an inflammatory reaction that leads to deadly clotting.
Joint replacements may gradually loosen and require
replacement. And any implant can cause infection.
Such devices entail engineering tradeoffs: utility
versus the strengths and weaknesses of their component materials. But a class of biomaterials called
bulk metallic glasses could transform that calculus for
future implanted medical devices, as well as for a host
of other engineered objects. Found nowhere else in
nature, these novel alloys may overcome many stubborn problems associated with today’s implants.
Shiny, gray, and pliable, bulk metallic glasses
resemble ordinary metals but are stronger and harder
than steel. They are nontoxic and resist corrosion
and wear, making them well suited to dwell inside
the body. They are elastic enough to change form and
spring back with ease. And they are easily shaped.
“Usually, metals processing is a big pain. It’s kind
of shocking—even 3D printing of metals is a big pain,”
says materials scientist Jan Schroers, PhD, professor of
mechanical engineering and materials science. “Metallic
glasses have this ability to be formed like plastics.”
For example, when heated to temperatures achievable in a kitchen oven, a platinum-based bulk metallic
glass softens to what Schroers describes as the consistency of refrigerated honey. “It doesn’t really deform
by itself under its own weight, but it’s soft enough [that
with modest] force you can deform it,” Schroers says.
In a cross-campus collaboration that has their
lab personnel learning both metallurgic and wet-lab
techniques, Schroers and Themis Kyriakides, PhD,
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associate professor of pathology and biomedical engineering at Yale School of Engineering and Applied
Science, are exploring how bulk metallic glasses perform as biomaterials.
For one thing, the materials are largely harmless
to mammalian cells yet hostile to bacteria. This property might make them useful as an antibacterial
coating on artificial joints, surgical instruments, or
hospital doorknobs.
Metallic glasses can also exert a druglike effect.
When cells interact with the surfaces of implanted
foreign bodies, they may go down the path of inflammation and rejection, or alternatively, toward a more
desirable repair-like response. Which path the cells
choose depends in part on the object’s tiniest surface
features—its nanotopography. These surface irregularities attract nearby proteins, which in turn influence
passing cells in various ways. Kyriakides and Schroers
can manipulate these cell behaviors by molding specific
patterns onto the surface of a metallic glass.
“We can dial in whatever we want to create in terms
of the surface—they could be nanopatterned, they
could be porous,” Kyriakides says. “These are [abilities]
that are usually restricted to polymers, and we can do
it with metals.”
That alone makes bulk metallic glasses “a fantastic toolbox,” Schroers says. “You can design cellular
responses that are desirable for a specific application.”
One such application could be a coronary artery
stent. Many stents on the market today are impregnated with a drug that diffuses into the body over time
to prevent clotting and formation of fibrous deposits.
But a bulk metallic glass stent with the right nanotopography could exert a similar effect, eliminating the
need for a drug.

In orthopaedics, alloys made from calcium, magnesium, and phosphorus may gradually disintegrate in the
body, a useful property for some types of bone hardware. Bulk metallic glasses can also be formed as strong,
light foams—picture a solidified sponge—the density of
which matches that of bone. That similarity is important
because conventional joint implants tend to be stiffer
than bone and absorb too much impact, allowing the
surrounding bone to atrophy from disuse and resulting in
a loosened, malfunctioning joint. An implant made from
a metallic glass foam could avert those complications.
The term glass refers to a material whose atoms
are arranged in an irregular non-crystalline pattern,
and which reacts to heating by becoming viscous. To
the eye and hand, metallic glasses look identical to

alloys based on the pricy element platinum, according
to Kyriakides: “Our cells have pretty expensive taste,”
he quips.
In 2014, Schroers founded a company, Supercool
Metals, based on his patented Yale-owned technique
for shaping bulk metallic glasses that can be used in
modified manufacturing operations typically used in
plastics processing.
“[We have] commercialized the ability to make very
complicated shapes you can’t make with any other process, in this material that’s very attractive for a large
range of applications,” he says. The company is working
with NASA to develop parts for robots and satellites, and
has developed a cellphone case with built-in flexible
buttons that may allow the development of waterproof

Themis Kyriakides

“We’re hoping that when
people see our results, they can get excited
about using these materials.
ordinary metal. But familiar metal objects’ atomic
structure is crystalline, comprising rows of atoms
bonded in a lattice. Metallic glasses are more like a liquid in which chaotically moving homogeneous atoms
have been frozen in time.
That homogeneity brings major advantages.
Ordinary metal alloys’ crystals meet one another along
countless microscopic edges called grain boundaries,
which are vulnerable to slippage and corrosion. By
contrast, metallic glasses are amorphous, homogeneous, and uniform in all directions throughout, making it harder for corrosive processes to gain a foothold.
Bulk metallic glasses are a brand-new material,
according to Schroers. On our planet, at least, the cooccurrence of different metallic elements in a heated
material that is abruptly cooled to form a glass has little
or no precedent. (The closest analogue is volcanic glass,
which consists mostly of silicon and oxygen, not metals.)
Oddly enough, cells survive and thrive on the new
exotic materials. They seem especially at home on

phones. Supercool Metals also manufactures tiny components for high-end watches.
Bulk metallic glasses are not ready for biomedical
use just yet, but it might not take long before they are.
In 2017, Kyriakides and Schroers built a glucose sensor
from a platinum-based bulk metallic glass that is much
more accurate than conventional sensors. Kyriakides
estimates that such a sensor could be developed for
clinical use within five years.
“We’re hoping that when people see our results,
they can get excited about using these materials,”
Kyriakides says. “We’ve barely scratched the surface.” /yale medicine magazine
Jenny Blair is a frequent contributor to Yale Medicine Magazine.
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Merle Waxman (foreground), Yale School of
Medicine’s associate dean
of women in medicine,
and the school ombudsperson, and Chenee Gallaher
(background) of the
school’s office of Diversity, Inclusion, and
Community Engagement,
examine portraits from
the school’s “Aperture:
Portraits of Women Faculty
in Medicine” exhibit.
Open to the public, the
portraits highlight some
previously overlooked faculty and administrators.

Art in Public Spaces:
A mirror on the community
A new exhibit aims to show the
school as it is, not as it was.
By John Curtis
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Laura Ment, at left; Valentina Greco, below; and Yetsa
Tuakli-Wosornu, at bottom,
are three of the women
featured in the first round of
portraits in the photography exhibit, “Aperture.”

of this institution but may
be considering becoming
part of it,” said Reisman.

T E R RY DAG R A D I P H OTO S

“The exhibits will say that
this is a place where people
are open to change.”
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A champion for
human rights gives back
 . ,  ’, is directing $5 million
from his estate to Yale School of Public Health to create an endowed professorship to support teaching and
research on improving LGBTQ mental health.
As a psychiatrist, Yale School
of Medicine alumnus David R.
Kessler, MD ’55, understands
the swirling mix of anxiety and
fear that can consume individuals who identify as part of the
LGBTQ community during their
struggle to come out about their
sexual orientation.
Kessler is not only trained
in such knowledge, he lived it.
From the intense anxiety attacks
he suffered as a closeted gay student in the 1950s to the fears of
persecution he and other closeted gay doctors shared in the
1970s, Kessler lived through a
turbulent time for LGBTQ people
in American history.
Now retired and living on the
West Coast, Kessler, who publicly affirmed his sexuality in
1978, wants to help others who
may be struggling to come out
or who are dealing with stigma,

42 ymm.yale.edu

oppression, and other issues that
affect their mental health.
“Coming out was a fantastic
experience for me and that’s
why I’m so interested in helping others, because I realized
from my own experience what a
meaningful, life-changing event
it is,” said Kessler (no relation to
former Yale School of Medicine
Dean David Aaron Kessler).
Kessler recently made a gift
of $200,000 to support the
work of Yale School of Public
Health Associate Professor John
Pachankis, PhD, and his Esteem
Research Group, which is dedicated to addressing the depression, anxiety, and substance use
that disproportionately affect

the LGBTQ community and can
erode healthy relationships and
behaviors. A clinical psychologist, Pachankis is internationally
known for his development of
novel psychosocial interventions
to improve mental health in
LGBTQ communities.
“John is just so energetic and
productive on the issue of coming out,” said Kessler. “I’m very
supportive of his work not only
in this country but internationally, which is really unbelievable. People around the world
are dealing with issues related to
coming out and John is studying
how it affects them in a scientific
and rigorous manner, which is
very impressive.”
Kessler also is directing
$5 million from his estate to Yale
School of Public Health (YSPH),
part of which is intended for
the creation of a David R. Kessler
Endowed Professorship. The
professorship and accompanying
resource fund will support teaching and research associated with
improving LGBTQ mental health.
The majority of the world still
lives in homophobic and transphobic conditions, including
many areas of the United States,
said Pachankis. In some states
and in some countries, so-called
conversion therapy is common
to try to turn gay people straight,
he said.
“As a stigmatized minority in
society, people who identify as
LGBTQ are subject to continuous
assaults on their self-esteem and
sense of belonging in their families, schools, and workplaces,”
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said Sten H. Vermund, MD, PhD,
dean and Anna M.R. Lauder
Professor of Public Health, who
has made improving LGBTQ
mental health a priority of his
administration. “I cannot think
of a higher-impact program in
which Dr. Kessler could invest
than Dr. Pachankis’ Esteem
Program. Kessler’s generosity
will ensure that LGBTQ mental
health research geared toward
preventive and therapeutic
interventions will be part of
YSPH under Pachankis’ leadership and in perpetuity.”
Pachankis’ research is dedicated to delivering effective
LGBTQ-affirming mental health
treatments to vulnerable populations in the United States and
around the world, such as those
in rural Appalachia, China, and
Eastern Europe. Some of the
programs Pachankis has initiated since arriving at Yale in
2013 involve improving training
for mental health providers,
delivering mental health treatment via the internet and mobile
applications, and finding ways
to sustain such treatments in
areas where LGBTQ stigma is
present and strong.
“David’s journey inspires
all of us to be as courageous
and creative as his generation
has been in living proudly and
meaningfully in the face of
societal and emotional barriers,” said Pachankis. “For a lot
of LGBTQ people, that journey
includes supporting the next
generation of LGBTQ individuals.
That’s certainly one of David’s

A recent designation
by David R. Kessler
ensures that the advocacy work he did on
behalf of LGBTQ mental wellness continues
long into the future.

major contributions and, in my
own way as a researcher and
teacher, I hope that it can be one
of mine.”
After coming out in San
Francisco, Kessler helped launch
the country’s first formal gay
doctors’ organization, Bay Area
Physicians for Human Rights. He
later served as president of the
National Gay Caucus of Members
of the American Psychiatric
Association, which became the
American Association of Gay and
Lesbian Psychiatrists. People
magazine highlighted his leadership and advocacy work in 1979.
He gave one of the eulogies at the
funeral of Harvey Milk, a key figure in the gay rights movement.
Kessler credits his friends
in the gay community with
providing the crucial support
he needed to acknowledge his
sexual orientation—and maintain his sanity—at a time when
the leading psychiatric diagnosis

manual, then the third edition of
the Diagnostics and Statistical
Manual of Mental Disorders or
DSM III, classified homosexuality
as a mental illness and perversion.
“I had been reading all this
nonsense psychiatrists had written about how sick gay people
are and I got so angry I couldn’t
stand it anymore,” Kessler
recalled. “I just said, ‘That’s it!
We need to organize and put an
end to this stuff and let people
know who we are and that there
are gay people everywhere and
we’re just like everyone else.’ ”
Despite San Francisco’s burgeoning gay community, organizing wasn’t easy, Kessler said.
Other medical professionals
were scared of losing patients
if their homosexuality became
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Jeorg Bewersdorf didn’t
start out looking to
become one of the foremost global experts in
creating bespoke microscopes. A serendipitous
class with future Nobel
Prize winner Stefan Hell
set Bewersdorf on his
path to success.
For more on Bewersdorf’s
unorthodox career,
visit ymm.yale.edu/
microscopes
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known, was a highly successful
five-year initiative to appoint
visiting lecturers and dramatically expand Yale’s archive of
LGBTQ materials, including
the papers of Kramer and felpublic. The early groups would
low activists David Mixner and
meet after dark in the shelHarvey Fierstein.
ter of members’ living rooms.
Kessler said he has been
There, discussion would drag
interested in creating something
on for hours about how memat Yale for years, but it took two
bers would be kept informed,
tries to get it done. The fi rst time
whether there should be a
he approached the university, in
printed membership list, who
the early 1990s, the people he
should possess the list, and
met with weren’t sure where the
what might happen if it fell
funds should be directed or how
into the wrong hands. Even
they might be used, and Kessler
the group’s initial chosen
chose instead to create the David
name—Bay Area Physicians for
R. Kessler Lectures in Lesbian
Human Rights—made no menand Gay Studies at his other
tion of homosexuality.
alma mater, the City University
After completing his psychiof New York.
atric residency at Yale in 1961,
A longtime supporter of
Kessler went on to become a facYale School of Medicine (YSM),
ulty member in the Department
of Psychiatry at the University of Kessler decided to make an
California San Francisco Medical estate gift to Yale School of
School and also a unit supervisor Public Health after speaking
with Vermund and YSM Deputy
at the Langley Porter Institute.
Dean and Chief Diversity
He retired as a clinical professor
Officer Darin Latimore,
of psychiatry in 1986, just as
MD, who introduced him to
his efforts were beginning to
Pachankis last year. Kessler
bear fruit.
hopes his endowment encourThe Lesbian and Gay Studies
ages others to support YSPH’s
Center at Yale, established in
ongoing efforts to improve
1986, was one of the fi rst of
mental health outcomes for the
its kind in the country. The
LGBTQ community.
Research Fund for Lesbian and
“Now Yale is ready, willing,
Gay Studies (FLAGS), established
and able, with a research proin 1992, supports faculty and
gram in full swing that is very
graduate student research, and
close to my heart,” Kessler said.
the university is widely known
“I am delighted to be able to
for its national conferences.
come back and do it even bigger
In 2001, Arthur Kramer ’49,
and better.”
made a major donation in honor
—Colin Poitras
of his brother, the writer, AIDS
activist, and ACT UP founder
Larry Kramer ’57. That led to
the establishment of the Larry
Kramer Initiative for Lesbian
and Gay Studies. LKI, as it was
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Taking aim at sickle
cell disease—an unfairly
neglected malady
Global Blood Therapeutics (GBT)
is a promising up-and-coming
biotechnology company in South
San Francisco. It is currently
focused on bringing voxelotor, a
potential treatment for sickle cell
disease (SCD), to the public—the
drug may be submitted for FDA
approval this year. If successful,
GBT stands to revolutionize health
in a traditionally marginalized
and overlooked community. Ted
W. Love, MD ’85, is its president
and chief executive officer.
If you think there’s a lot of
stress on Love’s shoulders, you
wouldn’t know it to talk with
him. “It’s a real honor, to be able
to work with all the talented
people here,” said Love. “That’s
one of the perks of success: better
access to bigger challenges, and
the type of professionals who like
to take on those challenges.”
Even during his childhood in
Alabama, Love was powerfully
attracted to a career in medicine,
though in interviews he’s also
expressed admiration for military pilots. The combination of
excitement, potential to change
the world for the better, and
opportunity for ethical leadership appealed to him. Perhaps
it isn’t terribly surprising, then,
that Love’s interest in medicine
led him to combine his passion
for science with the excitement
of entrepreneurialism.
His professional experiences prepared Love well for his
responsibilities at GBT. Once
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he completed his residency
and fellowship training in
internal medicine and cardiology at Harvard Medical School
(via Massachusetts General
Hospital), he went on to serve
in leadership roles at various
companies and committees,
including Genentech, Theravance
Biopharma, Nuvelo, Onyx
Pharmaceuticals, and California’s
Independent Citizens’ Oversight
Committee for stem-cell
research, among others.
After his last job, Love could
have easily retired to enjoy his
wine collection in Sonoma,
Calif., but GBT coaxed him back
into action. The reason for his
return was a lingering sense that
he could do more for the African
American community, which
suffers disproportionately from
SCD. Sickle cell was not viewed
as an “urgent” disease like some
other diseases that affect specific groups—evidence, perhaps,
of systemic bias—and GBT’s
voxelotor offered a rare possibility to create a viable treatment
in spite of the lack of traditional
market incentives. Voxelotor,
which is taken by mouth once
daily, prevents red blood cells
from becoming sickle-shaped
and breaking down by increasing their affinity for oxygen and
restoring normal hemoglobin
function. The premature breakdown of red blood cells in people
with SCD causes serious longterm consequences, including
anemia, organ damage, stroke,
and a shortened life span. “I
wanted to make a difference,

The training and
mentorship Ted Love received at Yale School of
Medicine from teachers
like Margaret “Peggy”
Bia helped prepare him
for the rigors of the
business world. Now,
the company of which
he’s CEO has a chance
to bring an effective
treatment for sickle cell
disease to market.

where in the past I didn’t have
the power to help,” said Love.
With a résumé like Love’s,
it’s hard to pick out specific
moments on which to focus.
Marriage and fatherhood (Love
is married with three daughters
and three granddaughters) have
been sources of positivity and
pride in his life, as has his educational path. Asked about his
memories of New Haven, Love
says that he learned important
lessons about what it meant to be
a doctor and practice medicine
while at Yale. He emphasized one
experience in particular.
“One day I was doing rounds,
and Margaret ‘Peggy’ Bia, MD,
FW ’78, was my attending,” said
Love. “It was a night shift, and
slow, and like most students I
was perhaps slightly overconfident in my abilities … I let more
patients in than usual, because I
knew I could handle it.”
Love said that the next thing
he knew, unexpected patients
flooded in, overwhelming him.
“I called Dr. Bia, asking for help,
hoping she could help me reduce
my patient load,” said Love. What

she told him left an indelible
mark on him as a young leader.
“She listened to me describe
the situation, patiently. And when
I was done, she said: ‘When the
going gets tough, the tough get
going.’ It was a long medical rotation, but I understood what she
meant: being a doctor is a responsibility. You promise to help people, that’s what you do. It’s on you.
I’ve never forgotten that lesson.”
Mentors like Bia, professor
emeritus of medicine (nephrology), who retired in 2018 after
40 years of service, are just part of
the reason Love remembers Yale
School of Medicine fondly. He
described relationships with other
students that have stood the test
of time, and opportunities that
the school opened up for him.
“The School of Medicine
played a big role in who I am
today,” said Love. “Ultimately,
I’m very grateful.”
—Adrian Bonenberger

Summer 2019 45

question and answer

Minimizing blood
vessel blockage
A LL CA RDIAC PROCEDURES

carry a risk of stroke because plaque

or calcium buildup can break off in small pieces, float up into the
brain, and block narrow blood vessels. A highly specialized tool
called an embolic protection device is currently used to prevent
some of the released debris from reaching the brain.
When Alexandra
Lansky, MD, professor
of medicine, finished
her first fellowship
in 1996, patients who
needed swift intervention to clear plaque that
threatened to block
blood vessels supplying their hearts had
limited options. Doctors
used a catheter with
an inflatable balloon
to squeeze the plaque
buildup against the
vessel wall. Later came
metallic stents that
could be inserted over
the plaque to widen
the vessel. Open-heart
surgery was the only
option for correcting
valve-related problems.
“Interventional cardiology was in its infancy,”
Lansky said. The Britishborn, French-raised cardiologist felt drawn to

{ To nominate a subject for Q&A, contact

the field by the opportunity to refine devices
that could save lives
and even permanently
address heart disease.
Since she arrived
at Yale eight years
ago, Lansky has built
a vast infrastructure of
clinical studies—with
countless moving parts,
such as active patient
recruitment, compliance, and research
approval—within the
section of cardiovascular
medicine at Yale School
of Medicine. Nearly
100 clinical trials
are ongoing under her
leadership as director of the Yale Heart
and Vascular Clinical
Research Program. She
also directs the Yale

Cardiovascular Research
Group, which designs,
plans, and executes
multicenter studies that
test medical devices in
clinical trials.
Within these roles,
Lansky started one
of the earliest clinical research programs
to offer transcatheter
aortic valve implantation (TAVI also known
as transcatheter aortic
valve replacement, or
TAVR). Performed in
patients with a narrowed aortic valve, this
procedure allows cardiologists to thread a
catheter through a blood
vessel in the leg up to the
heart to implant a new
aortic valve—thus avoiding open-heart surgery.
While cardiac
interventional technologies have drastically

Yale Medicine Magazine, 1 Church Street, Suite 300, New Haven, CT 06510, or email ymm@yale.edu.
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improved over the past
two decades, a stubborn
risk remains: strokes.
During any cardiac
procedures, plaque or
calcium buildup can
break off in small pieces,
float up into the brain,
and block a narrow
blood vessel there, causing a stroke. A highly
specialized tool called
an embolic protection
device is currently used
during TAVI to prevent
some of the released
debris from reaching
the brain. However, the
devices are not foolproof.
After years of experience,
Lansky decided she
could do better.
Why did you see a
need to invent another
embolic protection
device? During TAVI,
when the new valve
replaces the old valve,
some debris can come
loose. Stroke rates hover
around 3% in patients
who have this procedure.
Stroke risk is lower with
TAVI than with surgery.
However, our studies with
brain imaging show that
virtually all patients have
some degree of neurologic
injury—they just may not
show any symptoms. None
of the current deflection
technologies fully seals off
the cerebral vessels. The
device our team invented
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pressure drop without hav-

like TAVI are proving to be

in younger and low-risk

ing to rely on a wire or cre-

safe and effective, as well

patients with aortic ste-

ate potential complications

as reducing hospital-stay

nosis. He said, “This is a

and patient discomfort. This

times. This has added up

historic moment. We will

is expanding the diagnostic

to lower health care costs,

be telling our children and

value of the angiogram and

better outcomes, and hap-

grandchildren about these

allows us to more broadly

pier patients. This has

remarkable results.”

find out which patients
also working on integrating

is increasingly important

What will be the next
medical innovation in
heart disease? We are

diagnostics and on better

in the United States as we

finding better ways to iden-

patient selection

try to contain health care

tify which patients need

been a major initiative
of the United Kingdom’s
National Health Service and
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interventional treatment

should be treated. We are
artificial intelligence into

for treatment. I predict we

costs. We’ve found that

will have much more to

TAVI patients in the hospi-

report on this area in the

tal stay two to three days

near future.
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book review

The narrow gap between
animal and human viruses
By Cathy Shufro
When a pet prairie dog bit a

other Midwesterners got sick,

Ebola outbreak in West Africa.

years: clean water, clean food,

3-year-old in Wisconsin in

but nobody died, and no

Therefore, drug development

clean hands. When you give

2003, the child contracted an

monkeypox has since been

doesn’t appear in Andiman’s

aid, you are helping your-

infection endemic to central

reported in the United States.

and western Africa. How had

The prairie dog story

disease control; it requires

the monkeypox virus reached

illustrates Andiman’s under-

too much time and money.

derless agents. There are no

the American Midwest?

standing of why viruses

Instead, local and national

real borders anymore.”

threaten us. Because they

engagement come first in

Andiman knows some-

mutate “promiscuously,” he

stemming transmission,

thing about borderless viruses.

FW ’76, explores in Animal

explains, “viruses, unlike

including locating patients

He and nurse practitioner

Viruses and Humans: A

most living organisms, have

and tracing contacts; isolating

Leetha Fraulino established

Narrow Divide. The book

found ways to populate every

the sick; minimizing stigma;

the first AIDS program in New

teaches readers about mecha-

nook and cranny of the

alerting global health officials

Haven in 1982, at a time when

nisms that allow zoonotic

entire planet.” Global travel,

the minute an outbreak is

health care workers risked

viruses to move from animals

climate change, and refugees

discovered; and accepting

their own lives. “We didn’t

This is the kind of puzzle
that Warren A. Andiman, MD,

to humans and gives detailed

on the move have increased

outside help. Second, avoiding

even know it was a virus, and

accounts of viral outbreaks,

contact between animals and

epidemics requires perpetual

we knew nothing about the

including the severe acute

crowds of humans. Animal

surveillance, perhaps even

way it was transmitted. I was

respiratory syndrome (SARS),

groups that carry five or

testing people working with

very worried.” He directed the

rabies, and Ebola. Andiman,

more viruses that can infect

pigs, such as the half-million

Pediatric AIDS Care Program

professor emeritus of pediat-

us include birds, bats, pigs,

Americans employed by the

at Yale New Haven Hospital for

rics and public health at Yale,

primates, and rodents. To

pork industry.

32 years. When the program

also addresses the political,

those carriers, add insects.

economic, and environmental

“Imagine throwing billions

The third constituent

began, one in five mothers

of the trinity is foreign aid:

with HIV passed the virus

forces that are escalating the

of biting insects into the

building treatment cen-

on to their babies. By 1996,

threat of zoonoses worldwide.

already swirling cauldron

ters, improving roads, and

policies governing testing and

of animals and humans …”

providing protective cloth-

patient care had brought the

Andiman remarked.

ing for health workers and

transmission rate to zero.

In the case of the
Wisconsin girl bitten by
her pet, it turns out that an

When SARS appeared in

cold chains for medications.

Andiman imagined an

exotic-pet dealer in Illinois

southern China and began

Foreign aid can support

audience of educated but non-

had housed prairie dogs with

spreading in 2003, research-

what Andiman described in

expert readers during the

rodents imported from Africa,

ers around the world rallied

an interview as “very basic

two years he spent writing

including a Gambian rat car-

to work on vaccines and

public health practices we’ve

Animal Viruses and Humans.

rying monkeypox. Several

antivirals, but the epidemic

known about for a hundred

His aim was to explain how

ended without the help of

{ Send notices of new books to

the control of zoonotic dis-

either. The same thing hap-

eases can benefit all of us in

pened during the 2014-2015

“the family of humankind.”

Yale Medicine Magazine, 1 Church Street, Suite 300, New Haven, CT 06510, or email ymm@yale.edu.

48 ymm.yale.edu

self and your countrymen,
because these viruses are bor-
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“holy trinity” of zoonotic

end note

Fourth-year show
returns with a blast
A F T E R A T H R E E-Y E A R H I AT U S ,

an annual Yale School of Medicine tradition made its triumphant

return to the stage on Saturday, March 30, to very positive reviews.
Written, directed, and performed by graduating medical students and MD-PhD candidates, The
Final Master Course was a musical sendup of the Class of 2019’s medical-school experience. Many of
the parts were filled by enthusiastic students whose energy more than made up for their inexperience on stage, though some clearly had backgrounds in music and theater.
Formerly known as the “Second-Year Show” and held by second-year medical students, the
reborn Fourth-Year Show gave students a chance to poke lighthearted fun at themselves, one
another, beloved faculty, and administrators.
“We very much hope that this show will cement the newly revived tradition of the Fourth-Year
Show for years to come,” said Jack Zhao, fourth-year student and executive producer.
—Adrian Bonenberger
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